Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL39 (Enteramine, Serotonin, Thrombotonin) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
D1 receptor/Dopamine D1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2056] [GtoPdb: 214] [UniProtKB: P21728] | ||||||||
ChEMBL | Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells | B | 5.01 | pKd | 9690 | nM | Kd | J Med Chem (1996) 39: 850-859 [PMID:8632409] |
GtoPdb | - | - | 5 | pKi | - | - | - | Nature (1991) 350: 614-9 [PMID:1826762] |
D3 receptor/Dopamine D3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL234] [GtoPdb: 216] [UniProtKB: P35462] | ||||||||
ChEMBL | Basal binding towards Dopamine receptor D3 was evaluated using [35S]- GTP-gamma S radioligand | B | 6.28 | pEC50 | 523 | nM | EC50 | J Med Chem (2003) 46: 3822-3839 [PMID:12930145] |
D3 receptor/Dopamine D3 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3138] [GtoPdb: 216] [UniProtKB: P19020] | ||||||||
ChEMBL | Tested for binding affinity against dopamine receptor D3 expressed in Sf9 cells. | B | 5.63 | pKi | 2338 | nM | Ki | J Med Chem (1993) 36: 1499-1500 [PMID:8098771] |
microtubule affinity regulating kinase 4/MAP/microtubule affinity-regulating kinase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5754] [GtoPdb: 2100] [UniProtKB: Q96L34] | ||||||||
ChEMBL | Inhibition of MARK4 (unknown origin) ATPase activity using ATP as substrate incubated for 1.5 hr in presence of MgCl2 by Biomol green reagent based ELISA | B | 5.52 | pIC50 | 2990 | nM | IC50 | RSC Med Chem (2022) 13: 737-745 [PMID:35814926] |
MT1 receptor/Melatonin receptor 1A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1945] [GtoPdb: 287] [UniProtKB: P48039] | ||||||||
ChEMBL | Displacement of 2-[125I]iodomelatonin from human Melatonin receptor type 1A expressed in CHO cells | B | 4 | pKi | >100000 | nM | Ki | Bioorg Med Chem Lett (1997) 7: 2409-2414 |
MT2 receptor/Melatonin receptor 1B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1946] [GtoPdb: 288] [UniProtKB: P49286] | ||||||||
ChEMBL | Inhibition of 2-[125I]iodomelatonin binding to human Melatonin receptor type 1B expressed in CHO cells | B | 4 | pKi | >100000 | nM | Ki | Bioorg Med Chem Lett (1997) 7: 2409-2414 |
5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL214] [GtoPdb: 1] [UniProtKB: P08908] | ||||||||
ChEMBL | Binding affinity for 5-hydroxytryptamine 1A receptor was determined | B | 8.5 | pKd | 8.5 | - | pKD | J Med Chem (1993) 36: 1918-1919 [PMID:8515429] |
ChEMBL | Displacement of [3H]WAY100635 from human recombinant 5HT1A receptor | B | 5 | pKi | 10000 | nM | Ki | J Med Chem (2008) 51: 2887-2890 [PMID:18433113] |
ChEMBL | Displacement of [3H]8-OH-DPAT from 5HT1A receptor expressed in HEK293 cells after 2 hrs by liquid scintillation counting | B | 7.3 | pKi | <50 | nM | Ki | Bioorg Med Chem (2010) 18: 3345-3351 [PMID:20363635] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human recombinant 5-HT1A receptor expressed in HEK293-EBNA cells after 120 mins | B | 8.02 | pKi | 9.5 | nM | Ki | Eur J Med Chem (2013) 69: 920-930 [PMID:24161678] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human 5HT1A receptor expressed in CHO-K1 cell membranes incubated for 60 mins by microbeta scintillation counting analysis | B | 8.26 | pKi | 5.5 | nM | Ki | Eur J Med Chem (2019) 183: 111736-111736 [PMID:31586817] |
ChEMBL | Displacement of [3H]8-OH-DAPT from human recombinant 5-HT1A receptor expressed in CHO cells measured after 60 to 90 mins by radioligand completion assay relative to control | B | 8.35 | pKi | 4.5 | nM | Ki | J Med Chem (2021) 64: 13510-13523 [PMID:34467758] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells using [3H]8-OH-DPAT as radioligand | B | 8.4 | pKi | 3.98 | nM | Ki | J Med Chem (2003) 46: 5117-5120 [PMID:14613313] |
ChEMBL | Displacement of [3H]8-OH-DPAT from human 5-HT1A receptor expressed in CHO-K1 cell membranes incubated for 60 mins by microbeta scintillation counting method | B | 8.44 | pKi | 3.6 | nM | Ki | Eur J Med Chem (2019) 180: 383-397 [PMID:31325785] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from recombinant human 5HT1A receptor expressed in CHO cell membranes measured after 60 mins by microbeta scintillation counting analysis | B | 8.52 | pKi | 3 | nM | Ki | Eur J Med Chem (2019) 166: 144-158 [PMID:30703658] |
ChEMBL | In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus | B | 8.52 | pKi | 3 | nM | Ki | J Med Chem (1989) 32: 543-547 [PMID:2918500] |
ChEMBL | In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus | B | 8.55 | pKi | 2.8 | nM | Ki | J Med Chem (1989) 32: 543-547 [PMID:2918500] |
ChEMBL | The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor | B | 8.6 | pKi | 2.5 | nM | Ki | J Med Chem (1995) 38: 3602-3607 [PMID:7658447] |
ChEMBL | Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand | B | 8.61 | pKi | 2.48 | nM | Ki | Bioorg Med Chem Lett (1998) 8: 1407-1412 [PMID:9871775] |
ChEMBL | Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1A receptor in CHO-K1 cells | F | 8.61 | pKi | 2.48 | nM | Ki | J Med Chem (1996) 39: 4920-4927 [PMID:8960551] |
ChEMBL | Displacement of [3H]8-OH-DPAT from human 5-HT1A receptor transfected in CFO-K1 cells after 30 mins by liquid scintillation spectrometry | B | 8.68 | pKi | 2.08 | nM | Ki | Eur J Med Chem (2014) 85: 716-726 [PMID:25128671] |
ChEMBL | Binding affinity was measured on 5-hydroxytryptamine 1A receptor in AK cells transfected with human 5-HT1A gene labeled with [3H]-8-OH-DPAT | B | 8.77 | pKi | 1.7 | nM | Ki | J Med Chem (1994) 37: 2828-2830 [PMID:8071931] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human 5-HT1A receptor expressed in CHO-K1 cell membranes after 60 mins by microbeta scintillation counting analysis | B | 8.85 | pKi | 1.4 | nM | Ki | Bioorg Med Chem (2018) 26: 527-535 [PMID:29269256] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human 5-HT1A receptor expressed in CHO-K1 cell membranes after 60 mins by scintillation counting | B | 8.89 | pKi | 1.3 | nM | Ki | J Med Chem (2017) 60: 7483-7501 [PMID:28763213] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human 5-HT1A receptor expressed in CHO-K1 cell membranes after 60 mins by scintillation counting method | B | 8.89 | pKi | 1.3 | nM | Ki | Eur J Med Chem (2017) 137: 108-116 [PMID:28575721] |
ChEMBL | Displacement of [3H]8-OH-DPAT from human recombinant 5HT1A receptor | B | 8.9 | pKi | 1.26 | nM | Ki | J Med Chem (2008) 51: 2887-2890 [PMID:18433113] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human recombinant 5-HT1A receptor expressed in HEK293 cells incubated for 60 mins by microbeta2 scintillation counter | B | 8.92 | pKi | 1.2 | nM | Ki | Bioorg Med Chem (2019) 27: 4163-4173 [PMID:31383628] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human 5-HT1A receptor expressed in CHOK1 cell membranes after 60 mins by microbeta scintillation counting method | B | 8.96 | pKi | 1.1 | nM | Ki | Medchemcomm (2017) 8: 1690-1696 [PMID:30108880] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human 5-HT1A receptor expressed in CHOK1 cell membranes after 30 mins by liquid scintillation spectrometry | B | 9.04 | pKi | 0.91 | nM | Ki | Bioorg Med Chem Lett (2016) 26: 4052-4056 [PMID:27396505] |
ChEMBL | Displacement of [3H]8-OH-DPAT from 5-HT1A receptor (unknown origin) expressed in HEK293 cells by liquid scintillation counter | B | 9.05 | pKi | 0.9 | nM | Ki | Bioorg Med Chem (2013) 21: 856-868 [PMID:23332346] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from human 5HT1A receptor expressed in HEK293 cells | B | 9.21 | pKi | 0.62 | nM | Ki | Bioorg Med Chem (2012) 20: 4862-4871 [PMID:22748706] |
GtoPdb | - | - | 9.7 | pKi | - | - | - |
Biochem J (1992) 285 ( Pt 3): 933-8 [PMID:1386736]; Eur J Pharmacol (1998) 355: 245-56 [PMID:9760039]; Naunyn Schmiedebergs Arch Pharmacol (1999) 359: 447-53 [PMID:10431754]; Naunyn Schmiedebergs Arch Pharmacol (1998) 357: 205-17 [PMID:9550290]; Naunyn Schmiedebergs Arch Pharmacol (1997) 355: 682-8 [PMID:9205951]; Biosci Rep (2004) 24: 101-15 [PMID:15628665] |
ChEMBL | In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus | B | 8.22 | pIC50 | 6 | nM | IC50 | J Med Chem (1989) 32: 543-547 [PMID:2918500] |
ChEMBL | In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus | B | 8.25 | pIC50 | 5.6 | nM | IC50 | J Med Chem (1989) 32: 543-547 [PMID:2918500] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 1A receptor | B | 8.28 | pIC50 | 5.2 | nM | IC50 | J Med Chem (1992) 35: 4503-4505 [PMID:1447752] |
ChEMBL | In vitro inhibition of [125I]IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus | B | 8.7 | pIC50 | 2 | nM | IC50 | J Med Chem (1989) 32: 543-547 [PMID:2918500] |
ChEMBL | In vitro inhibition of azido-[125I]-IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus | B | 8.7 | pIC50 | 2 | nM | IC50 | J Med Chem (1989) 32: 543-547 [PMID:2918500] |
ChEMBL | In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor | B | 8.92 | pIC50 | 1.2 | nM | IC50 | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
ChEMBL | Agonist activity at human 5HT1A receptor expressed in CHOK1 cells incubated for 16 hrs followed by forskolin-stimulation and measured after 2 hrs by dual-glo luciferase reporter gene assay | B | 5.74 | pEC50 | 1800 | nM | EC50 | J Nat Prod (2019) 82: 3302-3310 [PMID:31789520] |
ChEMBL | Agonist activity at human 5-HT1A receptor expressed in U2OS cells assessed as beta-arrestin recruitment incubated for 5 hrs by Tango assay | F | 6.4 | pEC50 | 398.11 | nM | EC50 | Eur J Med Chem (2022) 233: 114218-114218 [PMID:35248836] |
ChEMBL | Agonist activity at human 5HT1A receptor expressed in C6 cells assessed as stimulation of [35S]GTPgammaS binding | F | 6.64 | pEC50 | 229.09 | nM | EC50 | J Med Chem (2007) 50: 5024-5033 [PMID:17803293] |
ChEMBL | Agonist activity at human 5-HT1A receptor expressed in CHO cells after 90 mins by beta-arrestin-2 recruitment assay | B | 6.77 | pEC50 | 169.82 | nM | EC50 | Bioorg Med Chem (2015) 23: 4824-4830 [PMID:26081758] |
ChEMBL | Agonist activity at 5HT1A receptor expressed in CHO cells by [35S]GTPgammaS binding assay | F | 6.82 | pEC50 | 150 | nM | EC50 | Bioorg Med Chem (2009) 17: 4873-4880 [PMID:19559623] |
ChEMBL | Agonist activity at 5HT1A receptor expressed in CHO cells assessed as stimulation of [35S]GTPgamma binding | F | 6.83 | pEC50 | 147 | nM | EC50 | J Med Chem (2010) 53: 1319-1328 [PMID:20041669] |
ChEMBL | Biased agonist activity at Gal4-VP16 transcription factor linked human 5-HT1A receptor expressed in human U2OS cells assessed as induction of beta-arrestin2 recruitment measured after 5 hrs by Tango assay | B | 6.89 | pEC50 | 128.82 | nM | EC50 | J Med Chem (2020) 63: 10946-10971 [PMID:32883072] |
ChEMBL | Biased agonist activity at Gal4-VP16 transcription factor linked human 5-HT1A receptor expressed in human U2OS cells assessed as stimulation of beta-arrestin recruitment measured after 5 hrs by Tango assay | B | 6.89 | pEC50 | 128.82 | nM | EC50 | J Med Chem (2019) 62: 2750-2771 [PMID:30721053] |
ChEMBL | Agonist activity at human 5-HT1A receptor expressed in CHO-K1 cells co-expressing Galpha16 assessed as increase in calcium mobilization measured for 30 secs by aequorin-derived luminescence assay | F | 7.01 | pEC50 | 97.7 | nM | EC50 | Bioorg Med Chem Lett (2018) 28: 2039-2049 [PMID:29730027] |
ChEMBL | Agonist activity at human 5-HT1A receptor expressed in CHO-K1 cells assessed as increase in calcium mobilization measured for 30 secs by aequorin-derived luminescence assay | F | 7.16 | pEC50 | 69.18 | nM | EC50 | Eur J Med Chem (2017) 137: 108-116 [PMID:28575721] |
ChEMBL | Biased agonist activity at human 5-HT1A receptor stably expressed in CHO-K1 cells co-expressing Galpha16/GPCR assessed as increase in calcium mobilization measured for 30 secs in presence of coelenterazine by aequorin-reporter gene based luminescence assay | F | 7.23 | pEC50 | 58.88 | nM | EC50 | J Med Chem (2020) 63: 10946-10971 [PMID:32883072] |
ChEMBL | Agonist activity at human recombinant 5-HT1A receptor expressed in CHOK1 cells measured after 1 hr by microbeta2 scintillation counter | B | 7.25 | pEC50 | 56.23 | nM | EC50 | Bioorg Med Chem (2019) 27: 4163-4173 [PMID:31383628] |
ChEMBL | Biased agonist activity at human recombinant 5-HT1A receptor stably expressed in CHO-K1 cells assessed as increase in calcium mobilization measured at 2 sec intervals for 180 secs by Fluo-4AM dye based fluorescence assay | F | 7.3 | pEC50 | 50.12 | nM | EC50 | J Med Chem (2019) 62: 2750-2771 [PMID:30721053] |
ChEMBL | Partial agonist activity at recombinant human 5-HT1A expressed in CHO-K1 cells by pathhunter beta-arrestin assay | B | 7.34 | pEC50 | 45.3 | nM | EC50 | Bioorg Med Chem Lett (2020) 30: 127358-127358 [PMID:32631554] |
ChEMBL | Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig | F | 7.37 | pEC50 | 43 | nM | EC50 | Bioorg Med Chem Lett (1995) 5: 2391-2396 |
ChEMBL | Agonist activity at 5HT1A receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 by FLIPR assay | B | 7.41 | pEC50 | 39 | nM | EC50 | J Med Chem (2013) 56: 4671-4690 [PMID:23675993] |
ChEMBL | Biased agonist activity at human 5-HT1A receptor stably expressed in CHO-K1 cells assessed as increase in ERK1/2 phosphorylation after 15 mins by Alphalisa assay | B | 7.48 | pEC50 | 33.11 | nM | EC50 | J Med Chem (2020) 63: 10946-10971 [PMID:32883072] |
ChEMBL | Biased agonist activity at human recombinant 5-HT1A receptor stably expressed in CHO-K1 cells assessed as increase in ERK1/2 phosphorylation levels incubated for 15 mins by Alphalisa assay | B | 7.48 | pEC50 | 33.11 | nM | EC50 | J Med Chem (2019) 62: 2750-2771 [PMID:30721053] |
ChEMBL | Biased agonist activity at human 5-HT1A receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation after 40 mins by LANCE Ultra cAMP kit-based TR-FRET assay | F | 7.51 | pEC50 | 30.9 | nM | EC50 | J Med Chem (2020) 63: 10946-10971 [PMID:32883072] |
ChEMBL | Biased agonist activity at human recombinant 5-HT1A receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation after 40 mins by LANCE Ultra cAMP kit-based TR-FRET assay | F | 7.51 | pEC50 | 30.9 | nM | EC50 | J Med Chem (2019) 62: 2750-2771 [PMID:30721053] |
ChEMBL | Agonist activity at human 5-HT1A receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation after 15 mins by ELISA | F | 7.56 | pEC50 | 27.54 | nM | EC50 | Bioorg Med Chem (2015) 23: 4824-4830 [PMID:26081758] |
ChEMBL | Agonist activity at serotonin 5-HT1A receptor (unknown origin) expressed in HEK293 cells assessed as induction of calcium flux after 60 mins by calcium 4-dye based FLIPR assay | F | 7.72 | pEC50 | 19 | nM | EC50 | J Med Chem (2018) 61: 10017-10039 [PMID:30383372] |
ChEMBL | Agonist activity at human recombinant 5HT1A receptor (unknown origin) stably expressed in CHO-K1 incubated for 30 mins by [35S]GTPgammaS binding assay | F | 7.74 | pEC50 | 18 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 126703-126703 [PMID:31627993] |
ChEMBL | Agonist activity at 5-HT1A receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 by Fluo-4 dye based FLIPR assay | B | 7.81 | pEC50 | 15.33 | nM | EC50 | Eur J Med Chem (2016) 123: 332-353 [PMID:27487565] |
ChEMBL | Agonist activity at human 5-HT1A receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP production incubated for 40 mins by TR-FRET assay | F | 7.96 | pEC50 | 10.96 | nM | EC50 | Eur J Med Chem (2022) 233: 114218-114218 [PMID:35248836] |
ChEMBL | Agonist activity at human 5-HT1A receptor expressed in CHO-K1 cells assessed as stimulation of ERK1/2 phosphorylation incubated for 15 mins by Alpha LISA assay | F | 8 | pEC50 | 10 | nM | EC50 | Eur J Med Chem (2022) 233: 114218-114218 [PMID:35248836] |
ChEMBL | Effect on forskolin stimulated adenylate cyclase activity at 5-hydroxytryptamine 1A receptor of guinea pig hippocampus. | F | 8 | pEC50 | 10 | nM | EC50 | J Med Chem (1992) 35: 4503-4505 [PMID:1447752] |
ChEMBL | Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S | F | 8.06 | pEC50 | 8.71 | nM | EC50 | J Med Chem (2003) 46: 5117-5120 [PMID:14613313] |
ChEMBL | Agonist activity at human 5HT1A receptor expressed in CHO-K1 cells by calcium 4 dye based FLIPR assay | F | 8.24 | pEC50 | 5.8 | nM | EC50 | Eur J Med Chem (2020) 207: 112709-112709 [PMID:32877805] |
ChEMBL | Agonist activity at human 5-HT1AR expressed in CHO-K1 cells assessed as increase in calcium flux by fluorimetric method | F | 8.24 | pEC50 | 5.7 | nM | EC50 | Eur J Med Chem (2018) 145: 790-804 [PMID:29407591] |
ChEMBL | Agonist activity at human recombinant 5-HT1A receptor expressed in CHOK1 cells measured after 1 hr by microbeta2 scintillation counter | B | 8.25 | pEC50 | 5.61 | nM | EC50 | Bioorg Med Chem (2019) 27: 4163-4173 [PMID:31383628] |
ChEMBL | Agonist activity at 5-HT1A receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay | F | 8.43 | pEC50 | 3.75 | nM | EC50 | Bioorg Med Chem (2013) 21: 856-868 [PMID:23332346] |
ChEMBL | Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor | B | 8.43 | pEC50 | 3.7 | nM | EC50 | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
ChEMBL | Agonist activity at 5-HT1A receptor (unknown origin) by calcium flux assay | F | 8.47 | pEC50 | 3.4 | nM | EC50 | J Med Chem (2023) 66: 12141-12162 [PMID:37646374] |
ChEMBL | Agonist activity at 5HT1A receptor (unknown origin) after 20 mins by [35S]GTP-gammaS binding assay | F | 8.52 | pEC50 | 3 | nM | EC50 | Bioorg Med Chem (2014) 22: 5838-5846 [PMID:25308766] |
ChEMBL | Agonist activity at human 5-HT1A receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay | F | 8.69 | pEC50 | 2.03 | nM | EC50 | Eur J Med Chem (2021) 214: 113243-113243 [PMID:33582388] |
ChEMBL | Agonistic activity at human 5HT1A in CHO cells by the inhibition of forskolin-stimulated cAMP accumulation | F | 9 | pEC50 | 1 | nM | EC50 | J Med Chem (2006) 49: 125-134 [PMID:16392798] |
ChEMBL | Agonist activity assessed by stimulation of [35S]GTP-gamma-S binding to human 5HT1A receptor expressed in CHO cells | F | 9.15 | pEC50 | 0.7 | nM | EC50 | Bioorg Med Chem Lett (2006) 16: 2101-2104 [PMID:16458504] |
ChEMBL | Agonistic activity at human 5HT1A receptor by [35S]GTP-gamma-S binding | F | 9.3 | pEC50 | 0.5 | nM | EC50 | J Med Chem (2006) 49: 125-134 [PMID:16392798] |
5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3737] [GtoPdb: 1] [UniProtKB: Q64264] | ||||||||
ChEMBL | Inhibitory activity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (1990) 33: 386-394 [PMID:2136918] |
5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL273] [GtoPdb: 1] [UniProtKB: P19327] | ||||||||
ChEMBL | Displacement of [3H]8-OH-DPAT from 5HT1A receptor in Rattus norvegicus (rat) cerebral cortex after 15 min by filter binding assay | B | 8.05 | pKi | 9 | nM | Ki | Med Chem Res (2008) 17: 507-514 |
ChEMBL | Ability to displace [3H]- -(OH)-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus | B | 8.14 | pKi | 7.3 | nM | Ki | J Med Chem (1998) 41: 728-741 [PMID:9513601] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus tissue. | B | 8.14 | pKi | 7.3 | nM | Ki | J Med Chem (1999) 42: 1556-1575 [PMID:10229626] |
ChEMBL | Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement | B | 8.32 | pKi | 4.79 | nM | Ki | J Med Chem (1996) 39: 126-134 [PMID:8568799] |
ChEMBL | Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [125I]trans-8-OH-PIPAT in membrane homogenates of hippocampal tissue of rat brain | B | 8.37 | pKi | 4.31 | nM | Ki | J Med Chem (1993) 36: 3161-3165 [PMID:8230102] |
ChEMBL | Displacement of [3H]8-OH-DPAT from rat 5HT1A receptor expressed in CHO cells | B | 8.52 | pKi | 3 | nM | Ki | Bioorg Med Chem (2008) 16: 6675-6681 [PMID:18562201] |
ChEMBL | Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand. | B | 8.52 | pKi | 3 | nM | Ki | J Med Chem (1987) 30: 1-12 [PMID:3543362] |
ChEMBL | Displacement of [3H]8OH-DPAT from 5HT1A in rat brain cerebral cortex after 15 mins by scintillation counting | B | 8.59 | pKi | 2.6 | nM | Ki | Eur J Med Chem (2011) 46: 4474-4488 [PMID:21816515] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from rat cerebral cortex 5HT1A receptor measured after 15 mins by liquid scintillation counter method | B | 8.64 | pKi | 2.3 | nM | Ki | Bioorg Med Chem (2016) 24: 3994-4007 [PMID:27377863] |
ChEMBL | The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand. | B | 8.68 | pKi | 2.1 | nM | Ki | J Med Chem (1995) 38: 2692-2704 [PMID:7629808] |
ChEMBL | Displacement of [3H]-8-OH-DPAT from 5HT1A receptor in rat hippocampal membranes after 20 mins | B | 8.68 | pKi | 2.1 | nM | Ki | Eur J Med Chem (2013) 63: 484-500 [PMID:23524160] |
ChEMBL | Binding affinity was determined against 5-hydroxytryptamine 1A receptor was determined in male Sprague-Dawley rat brain. | B | 8.7 | pKi | 2 | nM | Ki | J Med Chem (1990) 33: 755-758 [PMID:2299641] |
ChEMBL | Binding affinity to 5HT1A receptor in rat cortex membrane | B | 8.73 | pKi | 1.86 | nM | Ki | J Med Chem (2007) 50: 5024-5033 [PMID:17803293] |
ChEMBL | Binding affinity towards 5-hydroxytryptamine 1A receptor | B | 8.77 | pKi | 1.7 | nM | Ki | J Med Chem (1988) 31: 867-870 [PMID:2965244] |
ChEMBL | Displacement of [3H]8-OHDPAT from 5HT1A receptor in rat hippocampus | B | 8.8 | pKi | 1.6 | nM | Ki | J Med Chem (2009) 52: 6946-6950 [PMID:19831400] |
ChEMBL | Displacement of [3H]8-OHDPAT from 5HT1A receptor in rat hippocampus | B | 8.8 | pKi | 1.6 | nM | Ki | J Med Chem (2009) 52: 3548-3562 [PMID:19425598] |
ChEMBL | The compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand. | B | 8.8 | pKi | 1.58 | nM | Ki | J Med Chem (1999) 42: 4362-4379 [PMID:10543880] |
ChEMBL | Displacement of [3H]8-OH-DPAT from rat cortex 5-hydroxytryptamine 1A receptor | B | 8.28 | pIC50 | 5.2 | nM | IC50 | J Med Chem (1990) 33: 2087-2093 [PMID:2374139] |
ChEMBL | Binding affinity was measured against serotonin 5-hydroxytryptamine 1A receptor | B | 8.28 | pIC50 | 5.2 | nM | IC50 | J Med Chem (1994) 37: 2509-2512 [PMID:8057297] |
ChEMBL | Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand | B | 8.28 | pIC50 | 5.2 | nM | IC50 | Bioorg Med Chem Lett (1995) 5: 2391-2396 |
ChEMBL | In vitro inhibitory concentration against radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane. | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (1997) 40: 574-585 [PMID:9046348] |
ChEMBL | Inhibition of radiolabeled [3H]-8-OH-DPAT ligand binding to 5-hydroxytryptamine 1A receptor | B | 8.59 | pIC50 | 2.6 | nM | IC50 | J Med Chem (1997) 40: 3670-3678 [PMID:9357534] |
ChEMBL | Agonist activity at 5HT1A receptor in CRL:CD(SD)BR-COBS rat hippocampus assessed as increase in [35S]GTPgammaS binding | F | 6.49 | pEC50 | 323 | nM | EC50 | J Med Chem (2008) 51: 4529-4538 [PMID:18598015] |
ChEMBL | Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor | F | 8 | pEC50 | 10 | nM | EC50 | J Med Chem (1994) 37: 2509-2512 [PMID:8057297] |
5-HT1B receptor/Serotonin 1b (5-HT1b) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1898] [GtoPdb: 2] [UniProtKB: P28222] | ||||||||
GtoPdb | - | - | 8.4 | pKd | - | - | - |
Proc Natl Acad Sci USA (1992) 89: 3630-4 [PMID:1565658]; J Neurochem (1996) 67: 2096-103 [PMID:8863519] |
ChEMBL | Displacement of radiolabeled serotonin from human 5HT1B receptor | B | 7.74 | pKi | 18 | nM | Ki | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Displacement of [125I]CYP from human 5HT1B receptor | B | 7.85 | pKi | 14 | nM | Ki | J Med Chem (2011) 54: 5320-5334 [PMID:21726069] |
ChEMBL | The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta | B | 8.15 | pKi | 7.1 | nM | Ki | J Med Chem (1995) 38: 3602-3607 [PMID:7658447] |
ChEMBL | Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1B receptor in CHO-K1 cells | F | 8.17 | pKi | 6.76 | nM | Ki | J Med Chem (1996) 39: 4920-4927 [PMID:8960551] |
ChEMBL | Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1B receptor using [3H]5-CT as radioligand | B | 8.17 | pKi | 6.76 | nM | Ki | Bioorg Med Chem Lett (1998) 8: 1407-1412 [PMID:9871775] |
ChEMBL | Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand | B | 8.3 | pKi | 5.01 | nM | Ki | J Med Chem (2003) 46: 5117-5120 [PMID:14613313] |
ChEMBL | Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor | B | 8.32 | pKi | 4.8 | nM | Ki | J Med Chem (2003) 46: 265-283 [PMID:12519065] |
ChEMBL | Binding affinity to human 5-HT1B receptor by radioligand displacement assay | B | 8.4 | pKi | 4 | nM | Ki | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined using [3H]8-OH-DPAT as radioligand | B | 8.4 | pKi | 4 | nM | Ki | J Med Chem (1996) 39: 314-322 [PMID:8568822] |
ChEMBL | Binding affinity was measured on 5-hydroxytryptamine 1D receptor beta in CHO cells transfected with human 5-HT1D beta gene labeled with [3H]5-HT | B | 8.4 | pKi | 4 | nM | Ki | J Med Chem (1994) 37: 2828-2830 [PMID:8071931] |
ChEMBL | Displacement of [3H]5-hydroxytryptamine from human cloned 5HT1B receptor expressed in CHOK1 cells by liquid scintillation counting | B | 8.96 | pKi | 1.1 | nM | Ki | J Med Chem (2008) 51: 3609-3616 [PMID:18507369] |
GtoPdb | - | - | 9 | pKi | - | - | - |
Naunyn Schmiedebergs Arch Pharmacol (1999) 359: 447-53 [PMID:10431754]; Proc Natl Acad Sci USA (1992) 89: 3630-4 [PMID:1565658]; Br J Pharmacol (1997) 121: 737-42 [PMID:9208142]; Br J Pharmacol (1998) 125: 202-8 [PMID:9776361]; Mol Pharmacol (2000) 58: 1042-9 [PMID:11040052]; Eur J Pharmacol (1996) 314: 365-72 [PMID:8957260] |
ChEMBL | Displacement of radiolabeled serotonin from human 5HT1B receptor | B | 7.54 | pIC50 | 29 | nM | IC50 | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Inhibition of 5HT1B receptor | B | 7.8 | pIC50 | 16 | nM | IC50 | J Med Chem (2008) 51: 4150-4169 [PMID:18588282] |
ChEMBL | Binding affinity to 5-HT1B receptor (unknown origin) by radioligand displacement assay | B | 7.92 | pIC50 | 12 | nM | IC50 | Bioorg Med Chem (2013) 21: 2764-2771 [PMID:23582449] |
ChEMBL | Binding affinity to human 5-HT1B receptor by radioligand displacement assay | B | 8.19 | pIC50 | 6.5 | nM | IC50 | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 1B receptor | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (1992) 35: 4503-4505 [PMID:1447752] |
ChEMBL | Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus | B | 7.52 | pEC50 | 30 | nM | EC50 | J Med Chem (1990) 33: 2087-2093 [PMID:2374139] |
ChEMBL | Inhibition of forskolin-stimulated c-AMP formation by human 5-hydroxytryptamine 1B receptor expressed in CHO-K1 cells | F | 8.32 | pEC50 | 4.82 | nM | EC50 | J Med Chem (1996) 39: 4920-4927 [PMID:8960551] |
ChEMBL | The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Full Agonist | F | 8.33 | pEC50 | 4.67 | nM | EC50 | Bioorg Med Chem Lett (1998) 8: 1407-1412 [PMID:9871775] |
5-HT1B receptor in Mouse [GtoPdb: 2] [UniProtKB: P28334] | ||||||||
GtoPdb | - | - | 8.1 | pKi | - | - | - | Proc Natl Acad Sci USA (1992) 89: 3020-4 [PMID:1557407] |
5-HT1B receptor/Serotonin 1b (5-HT1b) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3459] [GtoPdb: 2] [UniProtKB: P28564] | ||||||||
ChEMBL | Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand. | B | 7.6 | pKi | 25 | nM | Ki | J Med Chem (1987) 30: 1-12 [PMID:3543362] |
ChEMBL | Evaluated for binding affinity towards 5-hydroxytryptamine 1B receptor | B | 8.27 | pKi | 5.4 | nM | Ki | J Med Chem (1988) 31: 867-870 [PMID:2965244] |
ChEMBL | Binding affinity was measured on 5-hydroxytryptamine 1B receptor in rat striatum labeled with [3H]5-HT | B | 8.27 | pKi | 5.4 | nM | Ki | J Med Chem (1994) 37: 2828-2830 [PMID:8071931] |
ChEMBL | Binding affinity was determined against 5-hydroxytryptamine 1B receptor was determined in male Sprague-Dawley rat brain. | B | 8.3 | pKi | 5 | nM | Ki | J Med Chem (1990) 33: 755-758 [PMID:2299641] |
ChEMBL | Displacement of [3H]5-HT from 5-HT1B receptor of rat frontal cortex homogenate | B | 8.46 | pKi | 3.47 | nM | Ki | J Med Chem (1988) 31: 1406-1412 [PMID:3385733] |
ChEMBL | The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand. | B | 8.6 | pKi | 2.51 | nM | Ki | J Med Chem (1999) 42: 4362-4379 [PMID:10543880] |
ChEMBL | The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand. | B | 8.6 | pKi | 2.5 | nM | Ki | J Med Chem (1995) 38: 2692-2704 [PMID:7629808] |
ChEMBL | Ability to displace [3H]5-HT bound to 5-hydroxytryptamine 1B receptor in rat striatum | B | 8.96 | pKi | 1.1 | nM | Ki | J Med Chem (1998) 41: 728-741 [PMID:9513601] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum. | B | 8.96 | pKi | 1.1 | nM | Ki | J Med Chem (1999) 42: 1556-1575 [PMID:10229626] |
ChEMBL | Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT as the radioligand. | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (1990) 33: 2087-2093 [PMID:2374139] |
ChEMBL | Displacement of [125I]CYP from rat cerebral cortex 5-HT1B receptor in the presence of isoproternol | B | 8.31 | pIC50 | 4.9 | nM | IC50 | Bioorg Med Chem (2016) 24: 1793-1810 [PMID:26988801] |
ChEMBL | Displacement of [125I]CYP from rat cerebral cortex 5HT1B receptor measured after 120 mins by scintillation counting method | B | 8.31 | pIC50 | 4.9 | nM | IC50 | Bioorg Med Chem (2017) 25: 471-482 [PMID:27876250] |
ChEMBL | Inhibition of radiolabeled [3H]-5-HT ligand binding to 5-hydroxytryptamine 1B receptor | B | 8.34 | pIC50 | 4.6 | nM | IC50 | J Med Chem (1997) 40: 3670-3678 [PMID:9357534] |
ChEMBL | Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra | B | 7.59 | pEC50 | 26 | nM | EC50 | J Med Chem (1990) 33: 2087-2093 [PMID:2374139] |
5-HT1D receptor/Serotonin 1d (5-HT1d) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1983] [GtoPdb: 3] [UniProtKB: P28221] | ||||||||
ChEMBL | Binding affinity for 5-hydroxytryptamine 1D receptor was determined | B | 7.9 | pKd | 7.9 | - | pKD | J Med Chem (1993) 36: 1918-1919 [PMID:8515429] |
ChEMBL | Binding affinity was measured on 5-hydroxytryptamine 1D receptor alpha in COS cells transfected with human 5-HT1D alpha gene labeled with [3H]5-HT | B | 8.26 | pKi | 5.5 | nM | Ki | J Med Chem (1994) 37: 2828-2830 [PMID:8071931] |
ChEMBL | Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1D receptor using [3H]-5-CT as radioligand | B | 8.3 | pKi | 5.06 | nM | Ki | Bioorg Med Chem Lett (1998) 8: 1407-1412 [PMID:9871775] |
ChEMBL | Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1D receptor in CHO-K1 cells | F | 8.3 | pKi | 5.06 | nM | Ki | J Med Chem (1996) 39: 4920-4927 [PMID:8960551] |
ChEMBL | Binding affinity to recombinant human 5-hydroxytryptamine 1D receptor alpha | B | 8.32 | pKi | 4.8 | nM | Ki | J Med Chem (1995) 38: 3602-3607 [PMID:7658447] |
ChEMBL | Binding affinity was determined against 5-hydroxytryptamine 1D receptor in bovine caudate homogenate | B | 8.52 | pKi | 3 | nM | Ki | J Med Chem (1990) 33: 755-758 [PMID:2299641] |
ChEMBL | In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor | B | 8.7 | pKi | 2 | nM | Ki | J Med Chem (1999) 42: 526-531 [PMID:9986723] |
ChEMBL | In vitro affinity human cloned 5-hydroxytryptamine 1D receptor alpha by [3H]5-HT displacement. | B | 8.77 | pKi | 1.7 | nM | Ki | J Med Chem (1996) 39: 314-322 [PMID:8568822] |
GtoPdb | - | - | 9 | pKi | - | - | - |
Naunyn Schmiedebergs Arch Pharmacol (1999) 359: 447-53 [PMID:10431754]; Proc Natl Acad Sci USA (1992) 89: 3630-4 [PMID:1565658]; Br J Pharmacol (1997) 121: 737-42 [PMID:9208142]; Br J Pharmacol (1998) 125: 202-8 [PMID:9776361]; Eur J Pharmacol (1996) 314: 365-72 [PMID:8957260]; Mol Pharmacol (1996) 50: 1567-80 [PMID:8967979]; Mol Pharmacol (1991) 40: 143-8 [PMID:1652050] |
ChEMBL | Displacement of [3H]5-hydroxytryptamine from human cloned 5HT1D receptor expressed in CHOK1 cells by liquid scintillation counting | B | 9.3 | pKi | 0.5 | nM | Ki | J Med Chem (2008) 51: 3609-3616 [PMID:18507369] |
ChEMBL | Inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (1990) 33: 2087-2093 [PMID:2374139] |
ChEMBL | Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand | B | 8.52 | pIC50 | 3 | nM | IC50 | Bioorg Med Chem Lett (1995) 5: 2391-2396 |
Serotonin 1d (5-HT1d) receptor in Pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4105] [UniProtKB: P79400] | ||||||||
ChEMBL | Binding activity against 5-hydroxytryptamine 1D receptor from pig caudate membrane using [3H]5-HT as radioligand | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (1995) 38: 1799-1810 [PMID:7752204] |
ChEMBL | Displacement of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1D receptor in pig caudate membrane | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (1993) 36: 1529-1538 [PMID:8496922] |
ChEMBL | Compound was tested for the displacement of [3H]-5-HT to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes | B | 8 | pIC50 | 10 | nM | IC50 | Bioorg Med Chem Lett (1993) 3: 993-997 |
5-HT1D receptor/Serotonin 1d (5-HT1d) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5450] [GtoPdb: 3] [UniProtKB: P28565] | ||||||||
ChEMBL | Binding affinity was measured against serotonin 5-hydroxytryptamine 1D receptor | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (1994) 37: 2509-2512 [PMID:8057297] |
ChEMBL | Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor | F | 8.28 | pEC50 | 5.2 | nM | EC50 | J Med Chem (1994) 37: 2509-2512 [PMID:8057297] |
Serotonin 1d (5-HT1d) receptor in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2304407] [UniProtKB: Q60484] | ||||||||
ChEMBL | Binding affinity against 5-hydroxytryptamine 1D receptor | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (1992) 35: 4503-4505 [PMID:1447752] |
ChEMBL | Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of guinea pig substantia nigra | B | 7.8 | pEC50 | 16 | nM | EC50 | J Med Chem (1990) 33: 2087-2093 [PMID:2374139] |
ChEMBL | Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra | B | 8.07 | pEC50 | 8.5 | nM | EC50 | Bioorg Med Chem Lett (1995) 5: 2391-2396 |
ChEMBL | Effect on forskolin stimulated adenylate cyclase activity at 5-HT1D receptor of guinea pig substantia nigra. | F | 8.28 | pEC50 | 5.2 | nM | EC50 | J Med Chem (1992) 35: 4503-4505 [PMID:1447752] |
5-ht1e receptor/Serotonin 1e (5-HT1e) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2182] [GtoPdb: 4] [UniProtKB: P28566] | ||||||||
ChEMBL | Displacement of [3H]5HT from 5-HT1E receptor (unknown origin) | B | 7.96 | pKi | 11 | nM | Ki | Bioorg Med Chem Lett (2014) 24: 576-579 [PMID:24365159] |
ChEMBL | Displacement of [3H]5HT from 5-HT1E receptor (unknown origin) | B | 7.97 | pKi | 10.72 | nM | Ki | Bioorg Med Chem Lett (2014) 24: 576-579 [PMID:24365159] |
GtoPdb | - | - | 8.2 | pKi | - | - | - |
Proc Natl Acad Sci USA (1992) 89: 5517-21 [PMID:1608964]; Proc Natl Acad Sci USA (1993) 90: 408-12 [PMID:8380639]; Eur J Pharmacol (2004) 484: 127-39 [PMID:14744596]; Bioorg Med Chem (2004) 12: 2545-52 [PMID:15110837] |
ChEMBL | Binding affinity was determined against 5-hydroxytryptamine 1E receptor in human cortical homogenate | B | 8.4 | pKi | 4 | nM | Ki | J Med Chem (1990) 33: 755-758 [PMID:2299641] |
5-HT1F receptor/Serotonin 1f (5-HT1f) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1805] [GtoPdb: 5] [UniProtKB: P30939] | ||||||||
GtoPdb | - | - | 8 | pKd | - | - | - | Proc Natl Acad Sci USA (1993) 90: 408-12 [PMID:8380639] |
GtoPdb | - | - | 8 | pKi | - | - | - |
Naunyn Schmiedebergs Arch Pharmacol (2005) 371: 169-77 [PMID:15900510]; Proc Natl Acad Sci USA (1993) 90: 408-12 [PMID:8380639]; Neuropharmacology (1997) 36: 569-76 [PMID:9225282] |
ChEMBL | In vitro effective concentration for inhibition of skolin-stimulated adenylate cyclase in cell line expressing human 5-hydroxytryptamine 1F receptor | F | 8.1 | pEC50 | 7.9 | nM | EC50 | J Med Chem (2001) 44: 4031-4034 [PMID:11708905] |
5-HT1F receptor in Rat [GtoPdb: 5] [UniProtKB: P30940] | ||||||||
GtoPdb | - | - | 7.2 | pIC50 | - | - | - | Proc Natl Acad Sci USA (1993) 90: 2184-8 [PMID:8384716] |
5-HT2A receptor/Serotonin 2a (5-HT2a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL224] [GtoPdb: 6] [UniProtKB: P28223] | ||||||||
GtoPdb | - | - | 8.9 | pKd | - | - | - | Biochem Pharmacol (1996) 51: 71-6 [PMID:8534270] |
ChEMBL | Displacement of [N-methyl-3H]LSD from human 5HT2A receptor expressed in HEK293 cells | B | 6.16 | pKi | 690 | nM | Ki | J Nat Prod (2006) 69: 1421-1424 [PMID:17067154] |
ChEMBL | Binding affinity was measured on 5-hydroxytryptamine 2A receptor in GF6 cells transfected with human 5-HT2A gene labeled with [3H]ketanserin | B | 6.29 | pKi | 510 | nM | Ki | J Med Chem (1994) 37: 2828-2830 [PMID:8071931] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand | B | 6.4 | pKi | 398.11 | nM | Ki | J Med Chem (2003) 46: 5117-5120 [PMID:14613313] |
ChEMBL | Displacement of [3H]ketanserin from human 5HT2A receptor expressed in tsA201 cell membranes after 1 hr by scintillation counting analysis | B | 6.49 | pKi | 323.59 | nM | Ki | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Displacement of [3H]methylspiperone form human cloned 5HT2A receptor expressed in african green monkey COS7 cells by scintillation spectroscopy | B | 6.49 | pKi | 320 | nM | Ki | J Nat Prod (2002) 65: 476-480 [PMID:11975483] |
ChEMBL | Displacement of [3H]ketanserin from human 5HT2A receptor expressed in tsA201 cell membranes after 1 hr by scintillation counting analysis | B | 6.49 | pKi | 320 | nM | Ki | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Displacement of [3H]INBMeO from human 5HT2A receptor expressed in human A549 cells | B | 6.8 | pKi | 160 | nM | Ki | Bioorg Med Chem (2008) 16: 6116-6123 [PMID:18468904] |
ChEMBL | Displacement of [3H]INBMeO from human 5HT2A receptor expressed in human HEK293 cells | B | 6.82 | pKi | 150 | nM | Ki | Bioorg Med Chem (2008) 16: 6116-6123 [PMID:18468904] |
ChEMBL | Displacement of [3H]ketanserin from human 5HT2A receptor expressed in human HEK293 cells | B | 6.89 | pKi | 130 | nM | Ki | Bioorg Med Chem (2008) 16: 6116-6123 [PMID:18468904] |
ChEMBL | Displacement of [3H]ketanserin from human 5HT2A receptor expressed in human A549 cells | B | 6.92 | pKi | 120 | nM | Ki | Bioorg Med Chem (2008) 16: 6116-6123 [PMID:18468904] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT2A receptor expressed in HEK cells by radioligand completion assay relative to control | B | 7.76 | pKi | 17.2 | nM | Ki | J Med Chem (2021) 64: 13510-13523 [PMID:34467758] |
ChEMBL | Displacement of [125I]DOI from human 5HT2A | B | 7.85 | pKi | 14 | nM | Ki | Bioorg Med Chem Lett (2006) 16: 677-680 [PMID:16257207] |
ChEMBL | Affinity for human 5-hydroxytryptamine 2A receptor expressed in mammalian cell line | B | 7.85 | pKi | 14 | nM | Ki | Bioorg Med Chem Lett (2004) 14: 2367-2370 [PMID:15081042] |
ChEMBL | Displacement of [125I]DOI from human 5HT2A receptor expressed in HEK293 cell membranes | B | 7.94 | pKi | 11.5 | nM | Ki | J Med Chem (2018) 61: 9121-9131 [PMID:30240563] |
ChEMBL | Displacement of [125I]DOI from cloned human 5HT2A receptor expressed in CHO cells | B | 8.09 | pKi | 8.2 | nM | Ki | J Med Chem (2006) 49: 318-328 [PMID:16392816] |
ChEMBL | Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand | B | 8.09 | pKi | 8.2 | nM | Ki | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
GtoPdb | - | - | 8.4 | pKi | - | - | - |
Naunyn Schmiedebergs Arch Pharmacol (2004) 370: 114-23 [PMID:15322733]; Biochem Pharmacol (1996) 51: 71-6 [PMID:8534270]; J Med Chem (2003) 46: 4188-95 [PMID:12954071]; Mol Pharmacol (1990) 38: 604-9 [PMID:2233697]; Mol Pharmacol (1994) 45: 277-86 [PMID:8114677]; J Biol Chem (1996) 271: 14672-5 [PMID:8663249] |
ChEMBL | Antagonist activity at recombinant human 5-HT2A expressed in human U2OS cells by pathhunter beta-arrestin assay | B | 7.55 | pIC50 | 27.9 | nM | IC50 | Bioorg Med Chem Lett (2020) 30: 127358-127358 [PMID:32631554] |
ChEMBL | Agonist activity at human 5HT2A S159A mutant transfected in HEK293T cells assessed as mini Galphaq recruitment measured for 2 hrs by luminescent assay | B | 5.78 | pEC50 | 1672 | nM | EC50 | J Med Chem (2022) 65: 12031-12043 [PMID:36099411] |
ChEMBL | Agonist activity at human 5HT2A S159A mutant transfected in HEK293T cells assessed as beta arrestin-2 recruitment measured for 2 hrs by luminescent assay | B | 6.18 | pEC50 | 661 | nM | EC50 | J Med Chem (2022) 65: 12031-12043 [PMID:36099411] |
ChEMBL | Partial agonist activity at human 5-HT2A receptor expressed in HEK293 cells preincubated for 1 hr at 37 degC followed by incubated for 15 mins at room temperature by IP-One assay | B | 6.52 | pEC50 | 302 | nM | EC50 | Bioorg Med Chem (2015) 23: 3933-3937 [PMID:25583099] |
ChEMBL | Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay | F | 6.82 | pEC50 | 150 | nM | EC50 | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay | F | 6.83 | pEC50 | 147.91 | nM | EC50 | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Agonist activity at human 5HT2A receptor transfected in HEK293T cells assessed as mini Galphaq recruitment measured for 2 hrs by luminescent assay | F | 6.89 | pEC50 | 130 | nM | EC50 | J Med Chem (2022) 65: 12031-12043 [PMID:36099411] |
ChEMBL | Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as intracellular IP3 accumulation | F | 6.9 | pEC50 | 125.89 | nM | EC50 | J Med Chem (2008) 51: 305-313 [PMID:18095642] |
ChEMBL | Agonist activity at human cloned 5HT2A receptor expressed in CHO cells assessed as myo-[3H]inositol hydrolysis | F | 7.15 | pEC50 | 70 | nM | EC50 | Bioorg Med Chem (2008) 16: 1966-1982 [PMID:18035544] |
ChEMBL | Agonist activity at 5-HT2A receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 by Fluo-4 dye based FLIPR assay | B | 7.33 | pEC50 | 47 | nM | EC50 | Eur J Med Chem (2016) 123: 332-353 [PMID:27487565] |
ChEMBL | Agonist activity at human smBiT-fused 5HT2A receptor expressed in CHO-K1 cells co-expressing IgBiT-fused beta-arrestin2 assessed as beta-arrestin2 recruitment by measuring increase in chemiluminescence intensity incubated for 2 hrs by NanoBiT luciferase assay | F | 7.55 | pEC50 | 28 | nM | EC50 | ACS Med Chem Lett (2024) 15: 337-339 [PMID:38505858] |
ChEMBL | Agonist activity at human smBiT-fused 5HT2A receptor expressed in CHO-K1 cells co-expressing IgBiT-fused beta-arrestin2 assessed as beta-arrestin2 recruitment by measuring increase in chemiluminescence intensity incubated for 2 hrs by NanoBiT luciferase assay | F | 7.6 | pEC50 | 25.12 | nM | EC50 | ACS Med Chem Lett (2024) 15: 337-339 [PMID:38505858] |
ChEMBL | Agonist activity at 5HT2A receptor (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay | B | 7.73 | pEC50 | 18.62 | nM | EC50 | US-20040213816-A1. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases (2004) |
ChEMBL | Agonist activity at 5HT2A receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 by FLIPR assay | B | 7.8 | pEC50 | 16 | nM | EC50 | J Med Chem (2013) 56: 4671-4690 [PMID:23675993] |
ChEMBL | Agonist activity at N-terminal HA-tagged human 5HT2A receptor transfected in CHO-K1 cells co-expressing C-terminal EYFP measured for 5.5 hrs by ONE-Glo reagent based luciferase assay | F | 7.92 | pEC50 | 12.1 | nM | EC50 | J Nat Prod (2023) 86: 1373-1384 [PMID:37306303] |
ChEMBL | Agonist activity at human 5HT2A receptor transfected in HEK293T cells assessed as beta arrestin-2 recruitment measured for 2 hrs by luminescent assay | F | 7.92 | pEC50 | 12.1 | nM | EC50 | J Med Chem (2022) 65: 12031-12043 [PMID:36099411] |
ChEMBL | Functional activity against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader | F | 7.96 | pEC50 | 11 | nM | EC50 | Bioorg Med Chem Lett (2004) 14: 2367-2370 [PMID:15081042] |
ChEMBL | Binding to human 5HT2A receptor expressed in CHO cells | B | 7.96 | pEC50 | 11 | nM | EC50 | Bioorg Med Chem Lett (2006) 16: 677-680 [PMID:16257207] |
ChEMBL | Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay | F | 8.12 | pEC50 | 7.6 | nM | EC50 | ACS Med Chem Lett (2011) 2: 929-932 [PMID:22778800] |
ChEMBL | Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay | F | 8.24 | pEC50 | 5.8 | nM | EC50 | J Med Chem (2009) 52: 1885-1902 [PMID:19284718] |
ChEMBL | Agonist activity at 5-HT2AR (unknown origin) stably expressed in HEK293 cells measured after 1 hr by fluorescence based Ca2+/Fluo-4 assay | B | 8.52 | pEC50 | 3 | nM | EC50 | ACS Med Chem Lett (2023) 14: 319-325 [PMID:36923922] |
ChEMBL | Agonist activity at 5-HT2AR (unknown origin) stably expressed in HEK293 cells measured after 1 hr by fluorescence based Ca2+/Fluo-4 assay | B | 8.53 | pEC50 | 2.95 | nM | EC50 | ACS Med Chem Lett (2023) 14: 319-325 [PMID:36923922] |
ChEMBL | Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay | F | 8.59 | pEC50 | 2.6 | nM | EC50 | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay | F | 8.59 | pEC50 | 2.57 | nM | EC50 | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Agonist activity at human 5-HT2A receptor expressed in human Flp-In-293 cells assessed as induction of calcium flux incubated for 1 hr by Fluo-4 direct dye based FLIPR assay | F | 8.63 | pEC50 | 2.35 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at human 5-HT2A receptor expressed in human Flp-In-293 cells assessed as induction of calcium flux incubated for 1 hr by Fluo-4 direct dye based FLIPR assay | F | 8.63 | pEC50 | 2.34 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay | F | 8.73 | pEC50 | 1.88 | nM | EC50 | J Med Chem (2015) 58: 1992-2002 [PMID:25633969] |
ChEMBL | Agonist activity at serotonin 5-HT2A receptor (unknown origin) expressed in HEK293 cells assessed as induction of calcium flux after 60 mins by calcium 4-dye based FLIPR assay | F | 8.8 | pEC50 | 1.6 | nM | EC50 | J Med Chem (2018) 61: 10017-10039 [PMID:30383372] |
ChEMBL | Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay | F | 8.81 | pEC50 | 1.55 | nM | EC50 | Bioorg Med Chem Lett (2013) 23: 3411-3415 [PMID:23602445] |
ChEMBL | Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay | F | 8.82 | pEC50 | 1.5 | nM | EC50 | Bioorg Med Chem Lett (2013) 23: 3411-3415 [PMID:23602445] |
ChEMBL | Agonist activity at 5-HT2A receptor (unknown origin) by calcium flux assay | F | 8.88 | pEC50 | 1.32 | nM | EC50 | J Med Chem (2023) 66: 12141-12162 [PMID:37646374] |
ChEMBL | Agonist activity at human 5HT2A receptor expressed in CHO-K1 cells by calcium 4 dye based FLIPR assay | F | 8.96 | pEC50 | 1.1 | nM | EC50 | Eur J Med Chem (2020) 207: 112709-112709 [PMID:32877805] |
ChEMBL | Partial agonist activity at human 5-HT2AR expressed in human Flp-In-T-REx-293 cells assessed as increase in calcium flux incubated for 60 mins followed by incubation for 30 mins in dark by Flou-4 dye based FLIPR assay | F | 9.2 | pEC50 | 0.63 | nM | EC50 | ACS Med Chem Lett (2024) 15: 99-106 [PMID:38229745] |
ChEMBL | Agonist activity at human 5-HT2A receptor expressed in Flp-In T-REx 293 cells assessed as induction of Gq-mediated calcium flux incubated for 1 hr by Flou4-AM dye based FLIPR assay | F | 9.29 | pEC50 | 0.51 | nM | EC50 | J Nat Prod (2020) 83: 461-467 [PMID:32077284] |
ChEMBL | Agonist activity at human 5-HT2A receptor expressed in Flp-In T-REx 293 cells assessed as induction of Gq-mediated calcium flux incubated for 1 hr by Flou4-AM dye based FLIPR assay | F | 9.29 | pEC50 | 0.51 | nM | EC50 | J Nat Prod (2020) 83: 461-467 [PMID:32077284] |
ChEMBL | Partial agonist activity at human 5-HT2AR expressed in human Flp-In-T-REx-293 cells assessed as increase in calcium flux incubated for 60 mins followed by incubation for 30 mins in dark by Flou-4 dye based FLIPR assay | F | 9.64 | pEC50 | 0.23 | nM | EC50 | ACS Med Chem Lett (2024) 15: 99-106 [PMID:38229745] |
5-HT2A receptor/Serotonin 2a (5-HT2a) receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5377] [GtoPdb: 6] [UniProtKB: P35363] | ||||||||
ChEMBL | Agonist activity at mouse 5-HT2A receptor expressed in Flp-In T-REx 293 cells assessed as induction of Gq-mediated calcium flux incubated for 1 hr by Flou4-AM dye based FLIPR assay | F | 9.28 | pEC50 | 0.53 | nM | EC50 | J Nat Prod (2020) 83: 461-467 [PMID:32077284] |
ChEMBL | Agonist activity at mouse 5-HT2A receptor expressed in Flp-In T-REx 293 cells assessed as induction of Gq-mediated calcium flux incubated for 1 hr by Flou4-AM dye based FLIPR assay | F | 9.28 | pEC50 | 0.52 | nM | EC50 | J Nat Prod (2020) 83: 461-467 [PMID:32077284] |
5-HT2A receptor/Serotonin 2a (5-HT2a) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL322] [GtoPdb: 6] [UniProtKB: P14842] | ||||||||
ChEMBL | The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand. | B | 5.9 | pKi | 1258.93 | nM | Ki | J Med Chem (1999) 42: 4362-4379 [PMID:10543880] |
ChEMBL | Displacement of [3H]ketanserin from 5HT2A receptor in rat cortex | B | 5.9 | pKi | 1258 | nM | Ki | J Med Chem (2009) 52: 3548-3562 [PMID:19425598] |
ChEMBL | Displacement of [3H]ketanserin from 5HT2A receptor in rat cortex | B | 5.9 | pKi | 1258 | nM | Ki | J Med Chem (2009) 52: 6946-6950 [PMID:19831400] |
ChEMBL | Displacement of [3H]ketanserin from 5HT2A in Sprague-Dawley rat frontal cortex membranes measured after 20 mins | B | 6.22 | pKi | 600 | nM | Ki | J Med Chem (2017) 60: 2605-2628 [PMID:28244748] |
GtoPdb | - | - | 6.5 | pKi | - | - | - |
Mol Pharmacol (2000) 58: 877-86 [PMID:11040033]; Circulation (2000) 102: 2836-41 [PMID:11104741]; J Pharmacol Exp Ther (1998) 286: 85-90 [PMID:9655845] |
ChEMBL | Displacement of [3H]DOI-HCL from 5HT2A in Sprague-Dawley rat frontal cortex membranes measured after 20 mins | B | 7.97 | pKi | 10.6 | nM | Ki | J Med Chem (2017) 60: 2605-2628 [PMID:28244748] |
ChEMBL | In vitro inhibitory constant against [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex | B | 9.52 | pKi | 0.3 | nM | Ki | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
ChEMBL | Displacement of [3H]-ketanserin from 5HT2A receptor low affinity component in rat brain cortical membranes after 15 mins by competition assay | B | 4.51 | pIC50 | 30600 | nM | IC50 | Eur J Med Chem (2013) 66: 122-134 [PMID:23792350] |
ChEMBL | Displacement of [3H]-ketanserin from 5HT2A receptor in rat brain cortical membranes after 15 mins by competition assay in presence of Gpp(NH)p | B | 4.89 | pIC50 | 13000 | nM | IC50 | Eur J Med Chem (2013) 66: 122-134 [PMID:23792350] |
ChEMBL | Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2A receptor | B | 5.63 | pIC50 | 2350 | nM | IC50 | J Med Chem (1997) 40: 3670-3678 [PMID:9357534] |
ChEMBL | Displacement of [3H]-ketanserin from 5HT2A receptor high affinity component in rat brain cortical membranes after 15 mins by competition assay | B | 6.22 | pIC50 | 600 | nM | IC50 | Eur J Med Chem (2013) 66: 122-134 [PMID:23792350] |
ChEMBL | Inhibition of [125I]DOI binding to 5HT2A receptor in rat cerebral cortex | B | 9.03 | pIC50 | 0.94 | nM | IC50 | J Med Chem (2006) 49: 318-328 [PMID:16392816] |
ChEMBL | In vitro inhibition of [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex | B | 9.05 | pIC50 | 0.9 | nM | IC50 | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
ChEMBL | In vitro relative agonist activity against 5-hydroxytryptamine 2A using PI assay in rat vascular smooth muscle cells | F | 6.45 | pEC50 | 351 | nM | EC50 | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
ChEMBL | Activity against 5HT2A mediated intracellular calcium mobilization by FLIPR in rat vascular smooth muscle cells | F | 7.24 | pEC50 | 57.9 | nM | EC50 | J Med Chem (2006) 49: 318-328 [PMID:16392816] |
ChEMBL | The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells | F | 7.25 | pEC50 | 55.8 | nM | EC50 | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
5-HT2B receptor/Serotonin 2b (5-HT2b) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1833] [GtoPdb: 7] [UniProtKB: P41595] | ||||||||
ChEMBL | Displacement of [3H]LSD from 5-HT2B receptor (unknown origin) | B | 7.87 | pKi | 13.49 | nM | Ki | Bioorg Med Chem Lett (2014) 24: 1489-1492 [PMID:24582985] |
ChEMBL | Inhibitory constant against cloned human 5-hydroxytryptamine 2B receptor using with [125I]- DOI radioligand | B | 7.89 | pKi | 13 | nM | Ki | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
ChEMBL | Displacement of [125I]DOI from cloned human 5HT2B receptor expressed in CHO cells | B | 7.89 | pKi | 13 | nM | Ki | J Med Chem (2006) 49: 318-328 [PMID:16392816] |
ChEMBL | Affinity for human 5-hydroxytryptamine 2B receptor expressed in mammalian cell line | B | 7.92 | pKi | 12 | nM | Ki | Bioorg Med Chem Lett (2004) 14: 2367-2370 [PMID:15081042] |
ChEMBL | Displacement of [3H]5-HT from human 5HT2B | B | 7.92 | pKi | 12 | nM | Ki | Bioorg Med Chem Lett (2006) 16: 677-680 [PMID:16257207] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT2B receptor expressed in HEK cells by radioligand completion assay relative to control | B | 7.97 | pKi | 10.8 | nM | Ki | J Med Chem (2021) 64: 13510-13523 [PMID:34467758] |
GtoPdb | - | - | 8.4 | pKi | - | - | - |
Naunyn Schmiedebergs Arch Pharmacol (2004) 370: 114-23 [PMID:15322733]; J Med Chem (2003) 46: 4188-95 [PMID:12954071]; Circulation (2000) 102: 2836-41 [PMID:11104741]; Mol Pharmacol (1994) 46: 227-34 [PMID:8078486]; Br J Pharmacol (2004) 143: 549-60 [PMID:15466450] |
ChEMBL | Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as intracellular IP3 accumulation | F | 7.6 | pEC50 | 25.12 | nM | EC50 | J Med Chem (2008) 51: 305-313 [PMID:18095642] |
ChEMBL | Agonist activity at human recombinant 5HT2B receptor assessed as induction of calcium mobilization by FLIPR assay | F | 7.96 | pEC50 | 11 | nM | EC50 | Bioorg Med Chem Lett (2009) 19: 4999-5003 [PMID:19646865] |
ChEMBL | Agonist activity at human cloned 5HT2B receptor expressed in HEK293-EBNA cells assessed as myo-[3H]inositol hydrolysis | F | 8.24 | pEC50 | 5.8 | nM | EC50 | Bioorg Med Chem (2008) 16: 1966-1982 [PMID:18035544] |
ChEMBL | Agonist activity at human 5-HT2BR expressed in CHO cells assessed as induction of IP1 accumulation after 30 mins by HTRF method | F | 8.35 | pEC50 | 4.5 | nM | EC50 | Eur J Med Chem (2018) 145: 790-804 [PMID:29407591] |
ChEMBL | Agonist activity at 5-HT2B receptor (unknown origin) by calcium flux assay | F | 8.62 | pEC50 | 2.4 | nM | EC50 | J Med Chem (2023) 66: 12141-12162 [PMID:37646374] |
ChEMBL | Functional activity against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader | F | 8.82 | pEC50 | 1.5 | nM | EC50 | Bioorg Med Chem Lett (2004) 14: 2367-2370 [PMID:15081042] |
ChEMBL | Binding to human 5HT2B receptor expressed in CHO cells | B | 8.82 | pEC50 | 1.5 | nM | EC50 | Bioorg Med Chem Lett (2006) 16: 677-680 [PMID:16257207] |
ChEMBL | Agonist activity at human 5-HT2B receptor expressed in human Flp-In-293 cells assessed as induction of calcium flux incubated for 1 hr by Fluo-4 direct dye based FLIPR assay | F | 8.84 | pEC50 | 1.46 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at human 5-HT2B receptor expressed in human Flp-In-293 cells assessed as induction of calcium flux incubated for 1 hr by Fluo-4 direct dye based FLIPR assay | F | 8.84 | pEC50 | 1.45 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Partial agonist activity at human 5-HT2BR expressed in human Flp-In-T-REx-293 cells assessed as increase in calcium flux incubated for 60 mins followed by incubation for 30 mins in dark by Flou-4 dye based FLIPR assay | F | 8.9 | pEC50 | 1.26 | nM | EC50 | ACS Med Chem Lett (2024) 15: 99-106 [PMID:38229745] |
ChEMBL | Partial agonist activity at human 5-HT2BR expressed in human Flp-In-T-REx-293 cells assessed as increase in calcium flux incubated for 60 mins followed by incubation for 30 mins in dark by Flou-4 dye based FLIPR assay | F | 8.92 | pEC50 | 1.19 | nM | EC50 | ACS Med Chem Lett (2024) 15: 99-106 [PMID:38229745] |
ChEMBL | Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay | F | 8.96 | pEC50 | 1.1 | nM | EC50 | Bioorg Med Chem Lett (2013) 23: 3411-3415 [PMID:23602445] |
ChEMBL | Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay | F | 8.97 | pEC50 | 1.07 | nM | EC50 | Bioorg Med Chem Lett (2013) 23: 3411-3415 [PMID:23602445] |
ChEMBL | Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay | F | 9.04 | pEC50 | 0.92 | nM | EC50 | J Med Chem (2015) 58: 1992-2002 [PMID:25633969] |
ChEMBL | Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay | F | 9.07 | pEC50 | 0.86 | nM | EC50 | ACS Med Chem Lett (2011) 2: 929-932 [PMID:22778800] |
ChEMBL | Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay | F | 9.3 | pEC50 | 0.5 | nM | EC50 | J Med Chem (2009) 52: 1885-1902 [PMID:19284718] |
ChEMBL | Agonist activity at 5-HT2B receptor (unknown origin) by calcium mobilization assay | F | 10.15 | pEC50 | 0.07 | nM | EC50 | Bioorg Med Chem Lett (2020) 30: 127511-127511 [PMID:32853682] |
5-HT2B receptor/Serotonin 2b (5-HT2b) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL323] [GtoPdb: 7] [UniProtKB: P30994] | ||||||||
GtoPdb | - | - | 8 | pKi | - | - | - | Mol Pharmacol (1993) 43: 419-26 [PMID:8450835] |
ChEMBL | Agonist activity at 5HT2b receptor in Wistar rat fundus measured for 90 secs | B | 8.38 | pEC50 | 4.19 | nM | EC50 | Eur J Med Chem (2015) 103: 289-301 [PMID:26363507] |
ChEMBL | Activity against 5HT2B receptor in longitudinal stomach fundus strips in wistar rats | F | 8.46 | pEC50 | 3.5 | nM | EC50 | J Med Chem (2006) 49: 318-328 [PMID:16392816] |
5-HT2C receptor/Serotonin 2c (5-HT2c) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL225] [GtoPdb: 8] [UniProtKB: P28335] | ||||||||
ChEMBL | Displacement of [3H]-mesulergine from 5HT2C receptor expressed in CHO cell membranes using 11 concentration of ligand after 90 mins by scintillation counting using complete competition binding curves analysis | B | 6.35 | pKi | 445 | nM | Ki | Bioorg Med Chem Lett (2012) 22: 2560-2564 [PMID:22381048] |
ChEMBL | Displacement of [3H]-mesulergine from 5HT2C receptor expressed in CHO cell membranes after 90 mins by scintillation counting | B | 6.67 | pKi | 214 | nM | Ki | Bioorg Med Chem Lett (2012) 22: 2560-2564 [PMID:22381048] |
ChEMBL | Displacement of [3H]mesulergine form human cloned 5HT2C receptor expressed in african green monkey COS7 cells by scintillation spectroscopy | B | 6.89 | pKi | 130 | nM | Ki | J Nat Prod (2002) 65: 476-480 [PMID:11975483] |
ChEMBL | Displacement of [3H]mesulergine from human 5HT2C receptor expressed in tsA201 cell membranes after 1 hr by scintillation counting analysis | B | 7.1 | pKi | 79.43 | nM | Ki | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Displacement of [3H]mesulergine from human 5HT2C receptor expressed in tsA201 cell membranes after 1 hr by scintillation counting analysis | B | 7.1 | pKi | 79 | nM | Ki | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptors in HEK 293 cells using [3H]mesulergine as radioligand | B | 7.3 | pKi | 50.12 | nM | Ki | J Med Chem (2003) 46: 5117-5120 [PMID:14613313] |
ChEMBL | Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 2C receptor binding site by using [3H]-MES as a radioligand. | B | 7.46 | pKi | 35 | nM | Ki | J Med Chem (1987) 30: 1-12 [PMID:3543362] |
ChEMBL | Displacement of [N-methyl-3H]LSD from human 5HT2C receptor expressed in HEK293 cells | B | 7.7 | pKi | 20 | nM | Ki | J Nat Prod (2006) 69: 1421-1424 [PMID:17067154] |
ChEMBL | Inhibitory constant against cloned human 5-hydroxytryptamine 2C receptor using with [125I]- DOI radioligand | B | 8.08 | pKi | 8.3 | nM | Ki | J Med Chem (2003) 46: 4188-4195 [PMID:12954071] |
ChEMBL | Displacement of [125I]DOI from cloned human 5HT2C receptor expressed in CHO cells | B | 8.08 | pKi | 8.3 | nM | Ki | J Med Chem (2006) 49: 318-328 [PMID:16392816] |
ChEMBL | Affinity for human 5-hydroxytryptamine 2C receptor expressed in mammalian cell line | B | 8.16 | pKi | 6.9 | nM | Ki | Bioorg Med Chem Lett (2004) 14: 2367-2370 [PMID:15081042] |
ChEMBL | Displacement of [3H]5-HT from human 5HT2C | B | 8.16 | pKi | 6.9 | nM | Ki | Bioorg Med Chem Lett (2006) 16: 677-680 [PMID:16257207] |
GtoPdb | - | - | 8.6 | pKi | - | - | - |
Naunyn Schmiedebergs Arch Pharmacol (2004) 370: 114-23 [PMID:15322733]; J Med Chem (2003) 46: 4188-95 [PMID:12954071]; J Neurochem (1999) 72: 2127-34 [PMID:10217294]; Synapse (2000) 35: 144-50 [PMID:10611640]; Eur J Pharmacol (2004) 483: 37-43 [PMID:14709324] |
ChEMBL | inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand | B | 7.09 | pIC50 | 81 | nM | IC50 | J Med Chem (1990) 33: 2087-2093 [PMID:2374139] |
ChEMBL | Antagonist activity at recombinant human 5-HT2C expressed in human U2OS cells by pathhunter beta-arrestin assay | B | 8.9 | pIC50 | 1.25 | nM | IC50 | Bioorg Med Chem Lett (2020) 30: 127358-127358 [PMID:32631554] |
ChEMBL | Partial agonist activity at human 5-HT2C receptor expressed in HEK293 cells preincubated for 1 hr at 37 degC followed by incubated for 15 mins at room temperature by IP-One assay | B | 6.72 | pEC50 | 190.55 | nM | EC50 | Bioorg Med Chem (2015) 23: 3933-3937 [PMID:25583099] |
ChEMBL | Agonist activity at 5HT2C receptor VGV isoform (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay | B | 7.29 | pEC50 | 51.29 | nM | EC50 | US-20040213816-A1. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases (2004) |
ChEMBL | Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay | F | 7.36 | pEC50 | 44 | nM | EC50 | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay | F | 7.36 | pEC50 | 43.65 | nM | EC50 | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as intracellular IP3 accumulation | F | 7.6 | pEC50 | 25.12 | nM | EC50 | J Med Chem (2008) 51: 305-313 [PMID:18095642] |
ChEMBL | Agonist activity at human recombinant 5HT2C receptor expressed in CHO K1 cells assessed as induction of calcium mobilization by FLIPR assay | F | 7.6 | pEC50 | 25 | nM | EC50 | Bioorg Med Chem Lett (2009) 19: 4999-5003 [PMID:19646865] |
ChEMBL | Agonist activity at human cloned 5HT2C receptor expressed in CHO cells assessed as myo-[3H]inositol hydrolysis | F | 7.62 | pEC50 | 24 | nM | EC50 | Bioorg Med Chem (2008) 16: 1966-1982 [PMID:18035544] |
ChEMBL | Agonist activity at human 5-HT2C INI receptor expressed in human HEK293 cells assessed as induction of beta-arrestin-2 recruitment incubated for 20 hrs by Tango assay | B | 7.66 | pEC50 | 21.88 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at human 5-HT2C INI receptor expressed in human HEK293 cells assessed as induction of beta-arrestin-2 recruitment incubated for 20 hrs by Tango assay | B | 7.68 | pEC50 | 21 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at tTA containing TEV cleavage site-fused 5-HT2C-INI receptor isoform (unknown origin) expressed in TEV-fused beta-arrestin2 expressing HEK cells assessed as induction of beta-arrestin2 recruitment after 20 hrs by Tango assay | B | 7.82 | pEC50 | 15.14 | nM | EC50 | J Med Chem (2017) 60: 6273-6288 [PMID:28657744] |
ChEMBL | Agonist activity at tTA containing TEV cleavage site-fused 5-HT2C-INI receptor isoform (unknown origin) expressed in TEV-fused beta-arrestin2 expressing HEK cells assessed as induction of beta-arrestin2 recruitment after 20 hrs by Tango assay | B | 7.82 | pEC50 | 15 | nM | EC50 | J Med Chem (2017) 60: 6273-6288 [PMID:28657744] |
ChEMBL | Functional activity against human 5-hydroxytryptamine 2C receptor expressed in CHO cells using fluorometric imaging plate reader | F | 8.77 | pEC50 | 1.7 | nM | EC50 | Bioorg Med Chem Lett (2004) 14: 2367-2370 [PMID:15081042] |
ChEMBL | Binding to human 5HT2C receptor expressed in CHO cells | B | 8.77 | pEC50 | 1.7 | nM | EC50 | Bioorg Med Chem Lett (2006) 16: 677-680 [PMID:16257207] |
ChEMBL | Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assay | F | 8.79 | pEC50 | 1.63 | nM | EC50 | Bioorg Med Chem Lett (2012) 22: 2560-2564 [PMID:22381048] |
ChEMBL | Agonist activity at 5-HT2CR (unknown origin) stably expressed in HEK293 cells measured after 1 hr by fluorescence based Ca2+/Fluo-4 assay | B | 8.92 | pEC50 | 1.2 | nM | EC50 | ACS Med Chem Lett (2023) 14: 319-325 [PMID:36923922] |
ChEMBL | Agonist activity at 5-HT2CR (unknown origin) stably expressed in HEK293 cells measured after 1 hr by fluorescence based Ca2+/Fluo-4 assay | B | 8.92 | pEC50 | 1.2 | nM | EC50 | ACS Med Chem Lett (2023) 14: 319-325 [PMID:36923922] |
ChEMBL | Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay | F | 9.06 | pEC50 | 0.87 | nM | EC50 | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay | F | 9.06 | pEC50 | 0.87 | nM | EC50 | J Med Chem (2013) 56: 1211-1227 [PMID:23301527] |
ChEMBL | Agonist activity at human 5HT2C receptor stably expressed in HEK293 cells co-expressing Gq assessed as induction of calcium mobilization measured at 1 sec interval for 60 secs by Fluo-4 calcium dye based FLIPR assay | F | 9.39 | pEC50 | 0.41 | nM | EC50 | J Med Chem (2020) 63: 4579-4602 [PMID:32282200] |
ChEMBL | Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay | F | 9.4 | pEC50 | 0.4 | nM | EC50 | Bioorg Med Chem Lett (2013) 23: 3411-3415 [PMID:23602445] |
ChEMBL | Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay | F | 9.46 | pEC50 | 0.35 | nM | EC50 | Bioorg Med Chem Lett (2013) 23: 3411-3415 [PMID:23602445] |
ChEMBL | Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay | F | 9.68 | pEC50 | 0.21 | nM | EC50 | J Med Chem (2015) 58: 1992-2002 [PMID:25633969] |
ChEMBL | Agonist activity at recombinant human unedited 5HT2C receptor isoform INI expressed in Flp-In-293 cells assessed as increase in calcium influx measured for 300 secs by Fluo-4 dye based FLIPR assay | F | 9.72 | pEC50 | 0.19 | nM | EC50 | Eur J Med Chem (2019) 182: 111626-111626 [PMID:31445232] |
ChEMBL | Agonist activity at recombinant human unedited 5HT2C receptor isoform INI expressed in Flp-In-293 cells assessed as increase in calcium influx measured for 300 secs by Fluo-4 dye based FLIPR assay | F | 9.72 | pEC50 | 0.19 | nM | EC50 | Eur J Med Chem (2019) 182: 111626-111626 [PMID:31445232] |
ChEMBL | Agonist activity at human 5-HT2C-INI receptor isoform expressed in Flp-IN HEK293 cells assessed as induction of Gq-mediated calcium flux measured every second for 5 mins by Fluo-4 dye based FLIPR assay | F | 9.74 | pEC50 | 0.18 | nM | EC50 | J Med Chem (2017) 60: 6273-6288 [PMID:28657744] |
ChEMBL | Agonist activity at human 5-HT2C receptor expressed in human Flp-In-293 cells assessed as induction of calcium flux incubated for 1 hr by Fluo-4 direct dye based FLIPR assay | F | 9.77 | pEC50 | 0.17 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at human 5-HT2C-INI receptor isoform expressed in Flp-IN HEK293 cells assessed as induction of Gq-mediated calcium flux measured every second for 5 mins by Fluo-4 dye based FLIPR assay | F | 9.77 | pEC50 | 0.17 | nM | EC50 | J Med Chem (2017) 60: 6273-6288 [PMID:28657744] |
ChEMBL | Agonist activity at human 5-HT2C receptor expressed in human Flp-In-293 cells assessed as induction of calcium flux incubated for 1 hr by Fluo-4 direct dye based FLIPR assay | F | 9.78 | pEC50 | 0.17 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at human 5-HT2C INI receptor expressed in human Flp-In-293 cells assessed as induction of calcium flux incubated for 1 hr by Fluo-4 direct dye based FLIPR assay | F | 9.85 | pEC50 | 0.14 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Agonist activity at human 5-HT2C INI receptor expressed in human Flp-In-293 cells assessed as induction of calcium flux incubated for 1 hr by Fluo-4 direct dye based FLIPR assay | F | 9.87 | pEC50 | 0.13 | nM | EC50 | J Med Chem (2016) 59: 9866-9880 [PMID:27726356] |
ChEMBL | Partial agonist activity at human 5-HT2CR expressed in human Flp-In-T-REx-293 cells assessed as increase in calcium flux incubated for 60 mins followed by incubation for 30 mins in dark by Flou-4 dye based FLIPR assay | F | 9.9 | pEC50 | 0.13 | nM | EC50 | ACS Med Chem Lett (2024) 15: 99-106 [PMID:38229745] |
ChEMBL | Partial agonist activity at human 5-HT2CR expressed in human Flp-In-T-REx-293 cells assessed as increase in calcium flux incubated for 60 mins followed by incubation for 30 mins in dark by Flou-4 dye based FLIPR assay | F | 9.92 | pEC50 | 0.12 | nM | EC50 | ACS Med Chem Lett (2024) 15: 99-106 [PMID:38229745] |
ChEMBL | Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay | F | 10.05 | pEC50 | 0.09 | nM | EC50 | ACS Med Chem Lett (2011) 2: 929-932 [PMID:22778800] |
ChEMBL | Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay | F | 10.05 | pEC50 | 0.09 | nM | EC50 | J Med Chem (2009) 52: 1885-1902 [PMID:19284718] |
5-HT2C receptor/Serotonin 2c (5-HT2c) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL324] [GtoPdb: 8] [UniProtKB: P08909] | ||||||||
ChEMBL | Binding affinity for 5-hydroxytryptamine 1C receptor was determined | B | 7.5 | pKd | 7.5 | - | pKD | J Med Chem (1993) 36: 1918-1919 [PMID:8515429] |
ChEMBL | The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand. | B | 7.5 | pKi | 31.62 | nM | Ki | J Med Chem (1999) 42: 4362-4379 [PMID:10543880] |
ChEMBL | Binding affinity was measured on 5-hydroxytryptamine 2C receptor in J1 cells transfected with rat 5-HT2C gene labeled with [3H]mesulergine | B | 7.64 | pKi | 23 | nM | Ki | J Med Chem (1994) 37: 2828-2830 [PMID:8071931] |
GtoPdb | - | - | 7.9 | pKi | - | - | - |
Circulation (2000) 102: 2836-41 [PMID:11104741]; J Neurochem (1997) 69: 1138-44 [PMID:9282936] |
ChEMBL | Binding affinity was determined against 5-hydroxytryptamine 1C receptor was determined in male Sprague-Dawley rat brain. | B | 8 | pKi | 10 | nM | Ki | J Med Chem (1990) 33: 755-758 [PMID:2299641] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 1C receptor | B | 7.09 | pIC50 | 81 | nM | IC50 | J Med Chem (1992) 35: 4503-4505 [PMID:1447752] |
ChEMBL | Inhibition of radiolabeled [3H]mesulergine ligand binding to 5-hydroxytryptamine 2C receptor | B | 7.38 | pIC50 | 42 | nM | IC50 | J Med Chem (1997) 40: 3670-3678 [PMID:9357534] |
ChEMBL | Activity against recombinant rat 5HT2C mediated intracellular calcium mobilization by FLIPR in SR3T3 cells | F | 8.55 | pEC50 | 2.8 | nM | EC50 | J Med Chem (2006) 49: 318-328 [PMID:16392816] |
5-HT3E/5-HT3B/5-HT3A/5-HT3D/5-HT3C/Serotonin 3 (5-HT3) receptor in Human (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL2094132] [GtoPdb: 377, 374, 373, 376, 375] [UniProtKB: A5X5Y0, O95264, P46098, Q70Z44, Q8WXA8] | ||||||||
ChEMBL | Binding affinity for the 5-hydroxytryptamine 3 receptor was evaluated in vitro by examining its ability to displace [3H]-BRL 43694. | B | 6.84 | pKi | 144.54 | nM | Ki | Bioorg Med Chem Lett (1993) 3: 205-208 |
ChEMBL | Binding affinity towards 5-hydroxytryptamine 3 receptor | B | 6.92 | pKi | 120 | nM | Ki | Bioorg Med Chem Lett (2002) 12: 2743-2747 [PMID:12217367] |
5-HT3A/5-HT3B/Serotonin 3 (5-HT3) receptor in Rat (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2094116] [GtoPdb: 373, 374] [UniProtKB: P35563, Q9JJ16] | ||||||||
ChEMBL | The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand. | B | 6.4 | pKi | 398.11 | nM | Ki | J Med Chem (1999) 42: 4362-4379 [PMID:10543880] |
ChEMBL | The ability to inhibit [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortices | B | 6.41 | pKi | 390 | nM | Ki | J Med Chem (1992) 35: 1486-1489 [PMID:1573641] |
ChEMBL | Binding affinity was measured on 5-hydroxytryptamine 3 receptor in NG-108 cells labeled with [3H]GR-65630 | B | 6.49 | pKi | 320 | nM | Ki | J Med Chem (1994) 37: 2828-2830 [PMID:8071931] |
ChEMBL | Ability to displace [3H]granisetron specifically bound to 5-hydroxytryptamine 3 receptor in rat cortical membrane | B | 6.92 | pKi | 120 | nM | Ki | J Med Chem (1998) 41: 728-741 [PMID:9513601] |
ChEMBL | Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor of rat cortical membrane | B | 6.92 | pKi | 120 | nM | Ki | J Med Chem (1999) 42: 1556-1575 [PMID:10229626] |
ChEMBL | Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement. | B | 7.06 | pKi | 87 | nM | Ki | Bioorg Med Chem Lett (1996) 6: 263-266 |
ChEMBL | Binding affinity for 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand | B | 7.18 | pKi | 66 | nM | Ki | J Med Chem (1995) 38: 2692-2704 [PMID:7629808] |
ChEMBL | Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate. | B | 6.14 | pIC50 | 727 | nM | IC50 | J Med Chem (1997) 40: 3670-3678 [PMID:9357534] |
5-HT3A/Serotonin 3a (5-HT3a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1899] [GtoPdb: 373] [UniProtKB: P46098] | ||||||||
ChEMBL | Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay | F | 6.3 | pEC50 | 500 | nM | EC50 | J Med Chem (2007) 50: 4616-4629 [PMID:17722904] |
ChEMBL | Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay | F | 6.34 | pEC50 | 457.09 | nM | EC50 | J Med Chem (2007) 50: 4616-4629 [PMID:17722904] |
ChEMBL | Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response | F | 6.75 | pEC50 | 178 | nM | EC50 | Bioorg Med Chem Lett (2011) 21: 58-61 [PMID:21146988] |
ChEMBL | Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 10 uM 5-chloroindole-induced increase in intracellular calcium release | F | 6.85 | pEC50 | 141 | nM | EC50 | Bioorg Med Chem Lett (2011) 21: 58-61 [PMID:21146988] |
5-HT3A/Serotonin 3a (5-HT3a) receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4972] [GtoPdb: 373] [UniProtKB: P23979] | ||||||||
ChEMBL | Agonist activity at mouse 5HT3A I187A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 4.05 | pEC50 | 90000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A Y143F receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 4.2 | pEC50 | 63000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A W183F receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 4.29 | pEC50 | 51000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A Y153F receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 4.31 | pEC50 | 49000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A Y153A receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 4.38 | pEC50 | 42000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A L184V receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 4.43 | pEC50 | 37000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A I187A receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 4.57 | pEC50 | 27000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A T181A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 4.62 | pEC50 | 24000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A H185F receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 4.68 | pEC50 | 20900 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A H185Y receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 4.76 | pEC50 | 17200 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A Y153F receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 4.82 | pEC50 | 15000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A L184V receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 4.96 | pEC50 | 11000 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A T186A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 5.02 | pEC50 | 9600 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A T181A receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 5.15 | pEC50 | 7100 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A H185F receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 5.21 | pEC50 | 6200 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A H185Y receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 5.29 | pEC50 | 5100 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A Q188A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 5.36 | pEC50 | 4400 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A I190V receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 5.36 | pEC50 | 4400 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at wild type mouse 5HT3A receptor expressed in Xenopus oocyte by two-electrode voltage patch clamp method | F | 5.47 | pEC50 | 3400 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Agonist activity at mouse 5HT3A S182A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method | F | 5.48 | pEC50 | 3300 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A T186A receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 5.54 | pEC50 | 2900 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A I190V receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 5.88 | pEC50 | 1320 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A Q188A receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 5.89 | pEC50 | 1300 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
ChEMBL | Selectivity ratio of EC50 for mouse 5HT3A S182A receptor mutant to EC50 for wild type mouse 5HT3A receptor | B | 6.01 | pEC50 | 980 | nM | EC50 | Bioorg Med Chem (2009) 17: 5796-5805 [PMID:19640719] |
5-HT3A/Serotonin 3a (5-HT3a) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2411] [GtoPdb: 373] [UniProtKB: P35563] | ||||||||
ChEMBL | Response at rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes | F | 4.92 | pEC50 | 12000 | nM | EC50 | Bioorg Med Chem Lett (2004) 14: 1849-1853 [PMID:15050614] |
5-HT4 receptor/Serotonin 4 (5-HT4) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1875] [GtoPdb: 9] [UniProtKB: Q13639] | ||||||||
GtoPdb | - | - | 8.8 | pKd | - | - | - | J Neurochem (2000) 74: 478-89 [PMID:10646498] |
ChEMBL | Displacement of [3H]GR-113808 from human 5HT4 isoform E receptor expressed in rat C6 cells by liquid scintillation counting | B | 5.98 | pKi | 1049 | nM | Ki | J Med Chem (2009) 52: 2214-2225 [PMID:19334715] |
ChEMBL | Displacement of [N-methyl-3H]GR-113808 from human 5HT4 receptor expressed in HEK293 cells | B | 6.3 | pKi | 500 | nM | Ki | J Nat Prod (2006) 69: 1421-1424 [PMID:17067154] |
ChEMBL | Binding affinity to recombinant human brain 5HT4 receptor by radio ligand binding assay | B | 6.61 | pKi | 246 | nM | Ki | Eur J Med Chem (2019) 182: 111596-111596 [PMID:31419776] |
ChEMBL | Displacement of [3H]GR-113808 from human recombinant 5HT4b receptor expressed in HEK293 cells by scintillation counting | B | 6.96 | pKi | 109.65 | nM | Ki | Eur J Med Chem (2009) 44: 2952-2959 [PMID:19223092] |
GtoPdb | - | - | 7 | pKi | - | - | - |
J Neurochem (1998) 70: 2252-61 [PMID:9603189]; Neuroreport (1997) 8: 3189-96 [PMID:9351641]; J Neurochem (1997) 69: 1810-9 [PMID:9349523]; J Neurochem (2000) 74: 478-89 [PMID:10646498]; Br J Pharmacol (2000) 129: 771-81 [PMID:10683202]; Br J Pharmacol (2000) 131: 827-35 [PMID:11030734]; Br J Pharmacol (2000) 130: 527-38 [PMID:10821780]; Br J Pharmacol (2004) 143: 549-60 [PMID:15466450]; Br J Pharmacol (2004) 143: 361-70 [PMID:15351779]; Naunyn Schmiedebergs Arch Pharmacol (2001) 363: 146-60 [PMID:11218067] |
ChEMBL | Displacement of [3H]GR-113808 from human 5HT4b receptor expressed in COS7 cell membrane by scintillation counting | B | 7.53 | pKi | 29.51 | nM | Ki | Eur J Med Chem (2009) 44: 2952-2959 [PMID:19223092] |
ChEMBL | Displacement of [3H]-GR 113808 from recombinant human brain 5HT4 receptor measured after 60 mins by radio ligand binding assay | B | 6.49 | pIC50 | 323 | nM | IC50 | Eur J Med Chem (2019) 182: 111596-111596 [PMID:31419776] |
ChEMBL | Activity at SER4 receptor expressed in HEK293 cells assessed as increase in calcium by calcium imaging assay | F | 7 | pEC50 | 100 | nM | EC50 | Nature (2007) 450: 553-556 [PMID:18033297] |
ChEMBL | Agonist activity at human 5HT4 isoform E receptor expressed in rat C6 cells assessed as cAMP accumulation by radio-immunoassay relative to 5HT | F | 7.92 | pEC50 | 12 | nM | EC50 | J Med Chem (2009) 52: 2214-2225 [PMID:19334715] |
5-HT4 receptor in Mouse [GtoPdb: 9] [UniProtKB: P97288] | ||||||||
GtoPdb | - | - | 7.2 | pKi | - | - | - | FEBS Lett (1996) 398: 19-25 [PMID:8946946] |
5-HT4 receptor/Serotonin 4 (5-HT4) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4317] [GtoPdb: 9] [UniProtKB: Q62758] | ||||||||
GtoPdb | - | - | 7.7 | pKd | - | - | - | Eur J Pharmacol (1996) 304: 231-5 [PMID:8813606] |
ChEMBL | Binding affinity towards 5-hydroxytryptamine 4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand | B | 6.73 | pKi | 187 | nM | Ki | J Med Chem (1997) 40: 608-621 [PMID:9046352] |
ChEMBL | Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatum by [3H]GR-113808 displacement. | B | 7.43 | pKi | 37.4 | nM | Ki | Bioorg Med Chem Lett (1996) 6: 263-266 |
GtoPdb | - | - | 8.2 | pKi | - | - | - |
EMBO J (1995) 14: 2806-15 [PMID:7796807]; Eur J Pharmacol (1996) 304: 231-5 [PMID:8813606]; Neuropharmacology (1997) 36: 671-9 [PMID:9225293] |
ChEMBL | Inhibition of radiolabeled [3H]GR-113808 ligand binding to 5-hydroxytryptamine 4 receptor | B | 6.83 | pIC50 | 147 | nM | IC50 | J Med Chem (1997) 40: 3670-3678 [PMID:9357534] |
ChEMBL | 5-hydroxytryptamine 4 receptor agonist activity was determined by the relaxation of the carbachol-contracted rat esophageal tunica muscularis mucosae | F | 8.43 | pIC50 | 3.7 | nM | IC50 | Bioorg Med Chem Lett (1994) 4: 1433-1436 |
ChEMBL | In vitro relaxation of carbachol pre-contracted rat oesophageal TMM. | F | 7.77 | pEC50 | 17.1 | nM | EC50 | Bioorg Med Chem Lett (1996) 6: 263-266 |
ChEMBL | 5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae | F | 8.2 | pEC50 | 6.31 | nM | EC50 | Bioorg Med Chem Lett (1993) 3: 1375-1378 |
Serotonin 4 (5-HT4) receptor in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5017] [UniProtKB: O70528] | ||||||||
ChEMBL | The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand. | B | 6.64 | pKi | 230 | nM | Ki | J Med Chem (1995) 38: 2692-2704 [PMID:7629808] |
ChEMBL | The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand. | B | 7 | pKi | 100 | nM | Ki | J Med Chem (1999) 42: 4362-4379 [PMID:10543880] |
ChEMBL | Displacement of [3H]GR-113808 from 5HT4 receptor in guinea pig striatum | B | 7 | pKi | 100 | nM | Ki | J Med Chem (2009) 52: 3548-3562 [PMID:19425598] |
ChEMBL | Displacement of [3H]GR-113808 from 5HT4 receptor in guinea pig striatum | B | 7 | pKi | 100 | nM | Ki | J Med Chem (2009) 52: 6946-6950 [PMID:19831400] |
ChEMBL | Agonist activity at 5HT4 receptor in guinea pig colon assessed as longitudinal muscle plexus contraction | F | 8 | pEC50 | 10 | nM | EC50 | Bioorg Med Chem Lett (2012) 22: 4849-4853 [PMID:22683222] |
ChEMBL | 5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum | F | 8.3 | pEC50 | 5 | nM | EC50 | J Med Chem (1997) 40: 608-621 [PMID:9046352] |
ChEMBL | 5-hydroxytryptamine 4 receptor agonist activity as increased response to electrical stimulation in guinea pig ileum | F | 8.3 | pEC50 | 5 | nM | EC50 | Bioorg Med Chem Lett (1994) 4: 1433-1436 |
5-HT5A receptor/Serotonin 5a (5-HT5a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3426] [GtoPdb: 10] [UniProtKB: P47898] | ||||||||
ChEMBL | Binding affinity for rodent 5-hydroxytryptamine 5A receptor | B | 6.6 | pKi | 250 | nM | Ki | J Med Chem (2003) 46: 2795-2812 [PMID:12825922] |
ChEMBL | Displacement of [3H]LSD from human 5HT5A receptor | B | 6.77 | pKi | 170 | nM | Ki | J Med Chem (2011) 54: 5320-5334 [PMID:21726069] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT5a receptor in HEK293 cells after 120 mins by scintillation counting | B | 6.89 | pKi | 130 | nM | Ki | J Med Chem (2017) 60: 349-361 [PMID:27997171] |
ChEMBL | Binding affinity towards human 5-hydroxytryptamine 5A receptor was evaluated using [3H]-5-CT as radioligand | B | 6.9 | pKi | 126 | nM | Ki | J Med Chem (2003) 46: 2795-2812 [PMID:12825922] |
GtoPdb | - | - | 6.9 | pKi | - | - | - |
FEBS Lett (1994) 355: 242-6 [PMID:7988681]; Eur J Pharmacol (2001) 418: 157-67 [PMID:11343685] |
ChEMBL | Displacement of radiolabeled serotonin from human 5HT5A receptor | B | 6.96 | pKi | 110 | nM | Ki | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Binding affinity to human 5-HT5a receptor by radioligand displacement assay | B | 7.09 | pKi | 82 | nM | Ki | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Binding affinity to human 5-HT5A receptor by radioligand displacement assay | B | 6.55 | pIC50 | 280 | nM | IC50 | Bioorg Med Chem (2013) 21: 2764-2771 [PMID:23582449] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT5a receptor in HEK293 cells after 120 mins by scintillation counting | B | 6.59 | pIC50 | 260 | nM | IC50 | J Med Chem (2017) 60: 349-361 [PMID:27997171] |
ChEMBL | Inhibition of human 5HT5A receptor | B | 6.74 | pIC50 | 184 | nM | IC50 | J Med Chem (2008) 51: 4150-4169 [PMID:18588282] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5HT5A receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method | B | 6.74 | pIC50 | 180 | nM | IC50 | Bioorg Med Chem (2017) 25: 471-482 [PMID:27876250] |
ChEMBL | Displacement of radiolabeled serotonin from human 5HT5A receptor | B | 6.74 | pIC50 | 180 | nM | IC50 | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT5A receptor expressed in HEK293 cells | B | 6.74 | pIC50 | 180 | nM | IC50 | Bioorg Med Chem (2016) 24: 1793-1810 [PMID:26988801] |
ChEMBL | Binding affinity to human 5-HT5a receptor by radioligand displacement assay | B | 6.8 | pIC50 | 160 | nM | IC50 | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Percent inhibition against 5-hydroxytryptamine 5A receptor at 1 uM | B | 7.1 | pIC50 | 79 | nM | IC50 | J Med Chem (2005) 48: 6887-6896 [PMID:16250647] |
5-HT5A receptor/Serotonin 5a (5-HT5a) receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3597] [GtoPdb: 10] [UniProtKB: P30966] | ||||||||
GtoPdb | - | - | 6.6 | pKi | - | - | - |
Mol Pharmacol (1993) 43: 313-9 [PMID:8450829]; Eur J Pharmacol (2001) 418: 157-67 [PMID:11343685]; FEBS Lett (1995) 377: 451-6 [PMID:8549774] |
ChEMBL | Binding affinity towards mouse 5-hydroxytryptamine 5A receptor | B | 6.82 | pKi | 150 | nM | Ki | J Med Chem (2003) 46: 2795-2812 [PMID:12825922] |
5-HT5A receptor in Rat [GtoPdb: 10] [UniProtKB: P35364] | ||||||||
GtoPdb | - | - | 6.6 | pKi | - | - | - | Proc Natl Acad Sci USA (1993) 90: 3452-6 [PMID:7682702] |
5-HT6 receptor/Serotonin 6 (5-HT6) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3371] [GtoPdb: 11] [UniProtKB: P50406] | ||||||||
ChEMBL | Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand | B | 6.9 | pKi | 125.89 | nM | Ki | J Med Chem (2003) 46: 5117-5120 [PMID:14613313] |
ChEMBL | Binding affinity to 5-Ht6 receptor (unknown origin) | B | 7 | pKi | 100 | nM | Ki | Bioorg Med Chem Lett (2016) 26: 2333-2338 [PMID:26996373] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 6 receptor | B | 7 | pKi | 100 | nM | Ki | Bioorg Med Chem Lett (2004) 14: 4569-4573 [PMID:15357994] |
ChEMBL | Displacement of radiolabeled serotonin from human 5HT6 receptor | B | 7.03 | pKi | 93 | nM | Ki | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Displacement of [3H]LSD from human 5HT6 receptor | B | 7.08 | pKi | 84 | nM | Ki | J Med Chem (2011) 54: 5320-5334 [PMID:21726069] |
ChEMBL | Binding affinity against human 5-hydroxytryptamine 6 receptor stably transfected to HEK 293 human embryonic kidney cells using [3H]-lysergic acid diethylamide as radioligand | B | 7.11 | pKi | 78 | nM | Ki | Bioorg Med Chem Lett (2000) 10: 2295-2299 [PMID:11055342] |
ChEMBL | Binding affinity for human 5-hydroxytryptamine 6 receptor expressed in HEK 293 human embryonic kidney cells, [3H]-lysergic acid diethylamide as radioligand | B | 7.12 | pKi | 75 | nM | Ki | J Med Chem (2000) 43: 1011-1018 [PMID:10715164] |
ChEMBL | Binding affinity to Homo sapiens (human) 5-HT6 receptor | B | 7.15 | pKi | 70 | nM | Ki | Med Chem Res (2005) 14: 1-18 |
ChEMBL | Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [3H]-LSD as radioligand | B | 7.19 | pKi | 65 | nM | Ki | J Med Chem (2003) 46: 2795-2812 [PMID:12825922] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in CHO cells after 120 mins by scintillation counting | B | 7.21 | pKi | 61 | nM | Ki | J Med Chem (2017) 60: 349-361 [PMID:27997171] |
ChEMBL | Binding affinity to human 5-HT6 receptor by radioligand displacement assay | B | 7.3 | pKi | 50 | nM | Ki | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in CHO cells | B | 7.48 | pKi | 33 | nM | Ki | J Med Chem (2014) 57: 4543-4557 [PMID:24805037] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in HEK-293 cells incubated for 60 mins by scintillation counting method | B | 7.48 | pKi | 33 | nM | Ki | Eur J Med Chem (2015) 92: 221-235 [PMID:25557493] |
GtoPdb | - | - | 7.5 | pKi | - | - | - |
J Neurochem (1996) 66: 47-56 [PMID:8522988]; Mol Pharmacol (1998) 54: 577-83 [PMID:9730917]; Mol Pharmacol (1997) 52: 515-523 [PMID:9284367] |
ChEMBL | Inhibition of human 5HT6 receptor | B | 6.58 | pIC50 | 262 | nM | IC50 | J Med Chem (2008) 51: 4150-4169 [PMID:18588282] |
ChEMBL | Displacement of radiolabeled serotonin from human 5HT6 receptor | B | 6.7 | pIC50 | 200 | nM | IC50 | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Binding affinity to human 5-HT6 receptor by radioligand displacement assay | B | 6.74 | pIC50 | 180 | nM | IC50 | Bioorg Med Chem (2013) 21: 2764-2771 [PMID:23582449] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in CHO cells after 120 mins by scintillation counting | B | 6.89 | pIC50 | 130 | nM | IC50 | J Med Chem (2017) 60: 349-361 [PMID:27997171] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in CHO cells | B | 6.92 | pIC50 | 120 | nM | IC50 | Bioorg Med Chem (2016) 24: 1793-1810 [PMID:26988801] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5HT6 receptor expressed in CHO cells measured after 120 mins by scintillation counting method | B | 6.92 | pIC50 | 120 | nM | IC50 | Bioorg Med Chem (2017) 25: 471-482 [PMID:27876250] |
ChEMBL | Binding affinity to human 5-HT6 receptor by radioligand displacement assay | B | 7 | pIC50 | 100 | nM | IC50 | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Displacement of [3H]LSD from human 5HT6 receptor by scintillation counting | B | 7.56 | pIC50 | 27.5 | nM | IC50 | J Med Chem (2010) 53: 2521-2527 [PMID:20170099] |
ChEMBL | Agonist activity at serotonin 5-HT6R receptor (unknown origin) expressed in HEK293 cells assessed as induction of calcium flux after 60 mins by calcium 4-dye based FLIPR assay | F | 7.36 | pEC50 | 43.6 | nM | EC50 | J Med Chem (2018) 61: 10017-10039 [PMID:30383372] |
ChEMBL | Agonist activity at human 5HT6 receptor expressed in CHO-K1 cells by calcium 4 dye based FLIPR assay | F | 7.38 | pEC50 | 42.1 | nM | EC50 | Eur J Med Chem (2020) 207: 112709-112709 [PMID:32877805] |
5-HT6 receptor in Rat [GtoPdb: 11] [UniProtKB: P31388] | ||||||||
GtoPdb | - | - | 7.9 | pKd | - | - | - | Neuropharmacology (1997) 36: 713-20 [PMID:9225298] |
GtoPdb | - | - | 7.9 | pKi | - | - | - |
Mol Pharmacol (1993) 43: 320-7 [PMID:7680751]; Neuropharmacology (1997) 36: 713-20 [PMID:9225298]; J Neurochem (1998) 71: 2169-77 [PMID:9798944]; Mol Pharmacol (1998) 54: 577-83 [PMID:9730917] |
5-HT7 receptor/Serotonin 7 (5-HT7) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3155] [GtoPdb: 12] [UniProtKB: P34969] | ||||||||
ChEMBL | Displacement of [3H]5-HT from human 5HT7 receptor transfected in CFO-K1 cells after 30 mins by liquid scintillation spectrometry | B | 8.4 | pKd | 3.98 | nM | Kd | Eur J Med Chem (2014) 85: 716-726 [PMID:25128671] |
ChEMBL | Displacement of [3H]5-HT from human 5-hydroxytryptamine 7 receptor | B | 8.09 | pKi | 8.1 | nM | Ki | J Med Chem (2003) 46: 2795-2812 [PMID:12825922] |
ChEMBL | Displacement of [3H]5-HT from recombinant human 5-HT7 receptor expressed in African green monkey COS7 cells | B | 8.1 | pKi | 7.94 | nM | Ki | Eur J Med Chem (2019) 183: 111705-111705 [PMID:31581003] |
ChEMBL | Displacement of [3H]D-lysergic acid diethylamide from 5HT7R (unknown origin) expressed in HEK293 cell membranes incubated for 1.5 hrs in absence of light by liquid scintillation counting | B | 8.22 | pKi | 6 | nM | Ki | Eur J Med Chem (2016) 123: 180-190 [PMID:27475109] |
ChEMBL | Binding affinity of compound towards rodent 5-hydroxytryptamine 7 receptor | B | 8.4 | pKi | 4 | nM | Ki | J Med Chem (2003) 46: 2795-2812 [PMID:12825922] |
ChEMBL | Binding affinity against 5-hydroxytryptamine 7 human receptors | B | 8.5 | pKi | 3.16 | nM | Ki | J Med Chem (2003) 46: 5117-5120 [PMID:14613313] |
ChEMBL | Displacement of [3H]-5-HT from human 5-HT7 receptor expressed in CHOK1 cell membranes after 30 mins by liquid scintillation spectrometry | B | 8.67 | pKi | 2.12 | nM | Ki | Bioorg Med Chem Lett (2016) 26: 4052-4056 [PMID:27396505] |
ChEMBL | Displacement of [3H]5-CT from human recombinant 5-HT7A receptor expressed in HEK cells by radioligand completion assay | B | 8.68 | pKi | 2.1 | nM | Ki | J Med Chem (2021) 64: 13510-13523 [PMID:34467758] |
ChEMBL | Displacement of [3H]5-HT from human 5-HT7 receptor expressed in HEK293 cells after 30 mins by microbeta counting analysis | B | 8.85 | pKi | 1.4 | nM | Ki | Eur J Med Chem (2014) 80: 8-35 [PMID:24763360] |
ChEMBL | Displacement of [3H]LSD from human 5-HT7 receptor expressed in CHO cells | B | 9.1 | pKi | 0.8 | nM | Ki | Eur J Med Chem (2015) 92: 221-235 [PMID:25557493] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT7 receptor expressed in CHO cells | B | 9.1 | pKi | 0.8 | nM | Ki | J Med Chem (2014) 57: 4543-4557 [PMID:24805037] |
GtoPdb | - | - | 9.6 | pKi | - | - | - |
Biochem Pharmacol (2003) 65: 435-40 [PMID:12527336]; Naunyn Schmiedebergs Arch Pharmacol (2001) 363: 620-32 [PMID:11414657]; Br J Pharmacol (1997) 122: 126-32 [PMID:9298538]; J Biol Chem (1993) 268: 23422-6 [PMID:8226867]; Br J Pharmacol (1998) 124: 1300-6 [PMID:9720804] |
ChEMBL | Displacement of radiolabeled serotonin from human 5HT7 receptor | B | 9.66 | pKi | 0.22 | nM | Ki | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT7 receptor expressed in CHO cells after 120 mins by scintillation counting | B | 9.77 | pKi | 0.17 | nM | Ki | J Med Chem (2017) 60: 349-361 [PMID:27997171] |
ChEMBL | Displacement of [3H]LSD from human 5HT7 receptor | B | 9.89 | pKi | 0.13 | nM | Ki | J Med Chem (2011) 54: 5320-5334 [PMID:21726069] |
ChEMBL | Binding affinity to human 5-HT7 receptor by radioligand displacement assay | B | 9.96 | pKi | 0.11 | nM | Ki | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Displacement of [3H]LSD from human 5HT7 receptor expressed in CHO cells | B | 8.59 | pIC50 | 2.55 | nM | IC50 | J Nat Prod (2003) 66: 535-537 [PMID:12713409] |
ChEMBL | Inhibition of human 5HT7 receptor | B | 8.82 | pIC50 | 1.5 | nM | IC50 | J Med Chem (2008) 51: 4150-4169 [PMID:18588282] |
ChEMBL | Displacement of radiolabeled serotonin from human 5HT7 receptor | B | 9.21 | pIC50 | 0.61 | nM | IC50 | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Binding affinity to human 5-HT7 receptor by radioligand displacement assay | B | 9.31 | pIC50 | 0.49 | nM | IC50 | Bioorg Med Chem (2013) 21: 2764-2771 [PMID:23582449] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT7 receptor expressed in CHO cells after 120 mins by scintillation counting | B | 9.33 | pIC50 | 0.47 | nM | IC50 | J Med Chem (2017) 60: 349-361 [PMID:27997171] |
ChEMBL | Binding affinity to human 5-HT7 receptor by radioligand displacement assay | B | 9.54 | pIC50 | 0.29 | nM | IC50 | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5-HT7 receptor expressed in CHO cells | B | 9.6 | pIC50 | 0.25 | nM | IC50 | Bioorg Med Chem (2016) 24: 1793-1810 [PMID:26988801] |
ChEMBL | Displacement of [3H]LSD from human recombinant 5HT7 receptor expressed in CHO cells measured after 120 mins by scintillation counting method | B | 9.6 | pIC50 | 0.25 | nM | IC50 | Bioorg Med Chem (2017) 25: 471-482 [PMID:27876250] |
ChEMBL | Agonist activity at 5-HT7R (unknown origin) transfected in HEK293 cells expressing tTA-dependent luciferase reporter and beta arrestin 2-TEV fusion gene assessed as beta arrestin recruitment incubated for 22 hrs by Tango assay | F | 6.95 | pEC50 | 112.2 | nM | EC50 | J Med Chem (2021) 64: 7453-7467 [PMID:34032427] |
ChEMBL | Agonist activity at 5-HT7R (unknown origin) transfected in HEK293 cells expressing tTA-dependent luciferase reporter and beta arrestin 2-TEV fusion gene assessed as beta arrestin recruitment incubated for 22 hrs by Tango assay | F | 6.96 | pEC50 | 110 | nM | EC50 | J Med Chem (2021) 64: 7453-7467 [PMID:34032427] |
ChEMBL | Agonist activity at human recombinant 5-HT7 receptor expressed in CHOK1 Hunter cell incubated for 30 to 60 mins by hit-hunter cAMP assay based chemiluminescence analysis | F | 7.15 | pEC50 | 70 | nM | EC50 | Bioorg Med Chem (2020) 28: 115578-115578 [PMID:32631561] |
ChEMBL | Agonist activity at tTA containing TCS cleavage site-fused 5-HT7 receptor (unknown origin) expressed in tTA-dependent luciferase reporter/TEV-fused beta-arrestin2 expressing HTLA cells assessed as induction of beta-arrestin2 recruitment after 22 hrs by Tango assay | F | 7.32 | pEC50 | 48 | nM | EC50 | J Med Chem (2018) 61: 7218-7233 [PMID:30028132] |
ChEMBL | Agonist activity at tTA containing TCS cleavage site-fused 5-HT7 receptor (unknown origin) expressed in tTA-dependent luciferase reporter/TEV-fused beta-arrestin2 expressing HTLA cells assessed as induction of beta-arrestin2 recruitment after 22 hrs by Tango assay | F | 7.32 | pEC50 | 47.86 | nM | EC50 | J Med Chem (2018) 61: 7218-7233 [PMID:30028132] |
ChEMBL | Agonist activity at human 5-HT7 expressed in HEK-293 cells assessed as increase in cAMP level after 45 mins by HTRF assay | F | 7.77 | pEC50 | 17 | nM | EC50 | J Med Chem (2014) 57: 6879-6884 [PMID:25073094] |
ChEMBL | Agonist activity at human recombinant 5HT7 receptor expressed in CHOK1 cells assessed as increase in cAMP levels by HTRF assay | F | 7.82 | pEC50 | 15 | nM | EC50 | J Med Chem (2009) 52: 2384-2392 [PMID:19326916] |
ChEMBL | Agonist activity at human 5-HT7R transfected in HEK293 cells assessed as Gs-mediated cAMP accumulation incubated for 30 mins by microplate reader analysis | F | 8.03 | pEC50 | 9.33 | nM | EC50 | J Med Chem (2021) 64: 7453-7467 [PMID:34032427] |
ChEMBL | Agonist activity at human 5-HT7 receptor expressed in CHO-K1 cells assessed as increase in serotonin-induced cAMP level after 1 hr by TR-FRET assay | F | 8.15 | pEC50 | 7 | nM | EC50 | Bioorg Med Chem Lett (2018) 28: 2039-2049 [PMID:29730027] |
ChEMBL | Agonist activity at human 5-HT7R expressed in HEK293 cells assessed as induction of cAMP levels treated for 10 mins measured after 30 mins by D2-dye based fluorescence assay | F | 8.24 | pEC50 | 5.8 | nM | EC50 | Eur J Med Chem (2016) 123: 180-190 [PMID:27475109] |
ChEMBL | Agonist activity at human 5-HT7R expressed in HEK293 cells assessed as induction of cAMP levels treated for 10 mins measured after 30 mins by D2-dye based fluorescence assay | F | 8.24 | pEC50 | 5.75 | nM | EC50 | Eur J Med Chem (2016) 123: 180-190 [PMID:27475109] |
ChEMBL | Agonist activity at human recombinant 5-HT7 receptor expressed in CHOK1 cells by LANCE TR-FRET assay | B | 8.24 | pEC50 | 5.7 | nM | EC50 | Bioorg Med Chem (2019) 27: 4163-4173 [PMID:31383628] |
ChEMBL | Agonist activity at human recombinant 5-HT7 receptor expressed in CHOK1 cells by LANCE TR-FRET assay | B | 8.27 | pEC50 | 5.37 | nM | EC50 | Bioorg Med Chem (2019) 27: 4163-4173 [PMID:31383628] |
ChEMBL | Agonist activity at human 5-HT7R transfected in HEK293 cells assessed as Gs-mediated cAMP accumulation incubated for 30 mins by microplate reader analysis | F | 8.35 | pEC50 | 4.5 | nM | EC50 | J Med Chem (2021) 64: 7453-7467 [PMID:34032427] |
ChEMBL | Agonist activity at human 5-HT7A receptor expressed in HEK cell membranes incubated for 20 mins by cAMP functional assay | F | 8.44 | pEC50 | 3.66 | nM | EC50 | Eur J Med Chem (2021) 214: 113243-113243 [PMID:33582388] |
5-HT7 receptor in Mouse [GtoPdb: 12] [UniProtKB: P32304] | ||||||||
GtoPdb | - | - | 8.3 | pKi | - | - | - | Mol Pharmacol (1993) 44: 229-36 [PMID:8394987] |
5-HT7 receptor/Serotonin 7 (5-HT7) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3223] [GtoPdb: 12] [UniProtKB: P32305] | ||||||||
ChEMBL | Binding affinity towards rat 5-hydroxytryptamine 7 receptor | B | 8 | pKi | 10 | nM | Ki | J Med Chem (2003) 46: 2795-2812 [PMID:12825922] |
ChEMBL | Displacement of [3H]LSD from rat recombinant 5HT7 receptor expressed in HEK293 cells at 10 uM | B | 8.13 | pKi | 7.33 | nM | Ki | Bioorg Med Chem (2007) 15: 5316-5321 [PMID:17517509] |
GtoPdb | - | - | 9.2 | pKi | - | - | - |
J Biol Chem (1993) 268: 18200-4 [PMID:8394362]; Proc Natl Acad Sci USA (1993) 90: 8547-51 [PMID:8397408] |
ChEMBL | Binding affinity at rat 5-hydroxytryptamine 7 receptor. | B | 9.22 | pKi | 0.6 | nM | Ki | J Med Chem (2003) 46: 5365-5374 [PMID:14640545] |
SERT/Serotonin transporter in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL313] [GtoPdb: 928] [UniProtKB: P31652] | ||||||||
ChEMBL | Ability to displace [3H]paroxetine bound to Serotonin transporter receptor in rat forebrain | B | 6.13 | pKi | 740 | nM | Ki | J Med Chem (1998) 41: 728-741 [PMID:9513601] |
ChEMBL | Binding affinity towards Serotonin transporter was determined in rat forebrain membrane | B | 6.13 | pKi | 740 | nM | Ki | J Med Chem (1999) 42: 1556-1575 [PMID:10229626] |
Organic cation transporter 3/Solute carrier family 22 member 3 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1770033] [GtoPdb: 1021] [UniProtKB: O88446] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in OCT3-expressing HRPE cells | F | 4.01 | pIC50 | 97000 | nM | IC50 | J Biol Chem (1998) 273: 32776-32786 [PMID:9830022] |
Vesicular monoamine transporter 2/Synaptic vesicular amine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1893] [GtoPdb: 1012] [UniProtKB: Q05940] | ||||||||
ChEMBL | Displacement of [3H]reserpine from human VMAT2 expressed in HEK293 cell membranes incubated for 60 mins by scintillation counting method | B | 5.11 | pKi | 7690 | nM | Ki | J Med Chem (2018) 61: 9121-9131 [PMID:30240563] |
ChEMBL | Displacement of [3H](+)-syn-Ethyl 1-(2-(2,4-Dioxo-1,2-dihydroquinazolin-3(4H)-yl)ethyl)-4-(4-fluorophenyl)piperidine-3-carboxylate from human VMAT2 expressed in HEK293 cell membranes incubated for 60 mins by scintillation counting method | B | 5.64 | pKi | 2290 | nM | Ki | J Med Chem (2018) 61: 9121-9131 [PMID:30240563] |
ChEMBL | Inhibition of human VMAT2 expressed in HEK293 cell membranes assessed as reduction in [3H[-5HT uptake pre-incubated for 10 mins before [3H[-5HT addition and measured after 6 mins | B | 5.84 | pIC50 | 1430 | nM | IC50 | J Med Chem (2018) 61: 9121-9131 [PMID:30240563] |
Vesicular monoamine transporter 2/Synaptic vesicular amine transporter in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4295886] [GtoPdb: 1012] [UniProtKB: Q8BRU6] | ||||||||
ChEMBL | Inhibition of VMAT2 in C57Bl/6J mouse striatal membranes assessed as reduction in [3H[-5HT uptake pre-incubated for 10 mins before [3H[-5HT addition and measured after 8 mins | B | 7.01 | pIC50 | 98 | nM | IC50 | J Med Chem (2018) 61: 9121-9131 [PMID:30240563] |
TA1 receptor/Trace amine-associated receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5857] [GtoPdb: 364] [UniProtKB: Q96RJ0] | ||||||||
ChEMBL | Agonist activity at recombinant human TAAR1 expressed in CHO-K1 cells assessed as increase in intracellular cAMP incubated for 30 mins by HTRF analysis | F | 4.45 | pEC50 | 35100 | nM | EC50 | ACS Med Chem Lett (2022) 13: 92-98 [PMID:35047111] |
D5 receptor in Human [GtoPdb: 218] [UniProtKB: P21918] | ||||||||
GtoPdb | - | - | 5.5 | pKi | - | - | - | Nature (1991) 350: 614-9 [PMID:1826762] |
5-HT3AB in Human [GtoPdb: 378] | ||||||||
GtoPdb | - | - | 6 | pKi | - | - | - | Neuropharmacology (2001) 41: 282-4 [PMID:11489465] |
GtoPdb | - | - | 5.8 | pEC50 | - | - | - |
Nature (1999) 397: 359-63 [PMID:9950429]; J Biol Chem (1999) 274: 30799-810 [PMID:10521471]; J Pharmacol Exp Ther (2005) 315: 771-6 [PMID:16081679]; Mol Pharmacol (2000) 57: 1114-22 [PMID:10825381] |
5-HT3A in Human [GtoPdb: 379] | ||||||||
GtoPdb | - | - | 6.9 | pKi | - | - | - |
Mol Pharmacol (1998) 53: 202-12 [PMID:9463477]; Neuropharmacology (2001) 41: 282-4 [PMID:11489465]; Br J Pharmacol (1996) 118: 1237-45 [PMID:8818349]; Eur J Pharmacol (2000) 409: 195-201 [PMID:11104834] |
GtoPdb | - | - | 6.4 | pEC50 | - | - | - |
Nature (1999) 397: 359-63 [PMID:9950429]; Mol Pharmacol (1995) 48: 1054-62 [PMID:8848005]; Mol Pharmacol (1995) 48: 407-16 [PMID:7565620]; J Biol Chem (1999) 274: 30799-810 [PMID:10521471]; Mol Pharmacol (1998) 53: 202-12 [PMID:9463477]; J Pharmacol Exp Ther (2005) 315: 771-6 [PMID:16081679]; Mol Pharmacol (2000) 57: 1114-22 [PMID:10825381] |
Proton-coupled Amino acid Transporter 1 in Human [GtoPdb: 1161] [UniProtKB: Q7Z2H8] | ||||||||
GtoPdb | - | - | 2.2 | pKi | 5700000 | nM | Ki | FASEB J (2005) 19: 1468-73 [PMID:16126914] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]